WO2018174448A1 - Composition for treating and preventing climacteric syndrome containing combined herbal medicinal extract of white atractylis, mori fructus, chinese matrimony vine, longan, achyranthes, eucommia bark, and asparagus cochinchinensis merr. as active ingredient, and use of same - Google Patents

Composition for treating and preventing climacteric syndrome containing combined herbal medicinal extract of white atractylis, mori fructus, chinese matrimony vine, longan, achyranthes, eucommia bark, and asparagus cochinchinensis merr. as active ingredient, and use of same Download PDF

Info

Publication number
WO2018174448A1
WO2018174448A1 PCT/KR2018/002803 KR2018002803W WO2018174448A1 WO 2018174448 A1 WO2018174448 A1 WO 2018174448A1 KR 2018002803 W KR2018002803 W KR 2018002803W WO 2018174448 A1 WO2018174448 A1 WO 2018174448A1
Authority
WO
WIPO (PCT)
Prior art keywords
vitamin
baekchul
combination
wolfberry
astronomical dong
Prior art date
Application number
PCT/KR2018/002803
Other languages
French (fr)
Korean (ko)
Inventor
김순일
류종훈
Original Assignee
김순일
올만식품 유한회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김순일, 올만식품 유한회사 filed Critical 김순일
Publication of WO2018174448A1 publication Critical patent/WO2018174448A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284Atractylodes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/21Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/46Eucommiaceae (Eucommia family), e.g. hardy rubber tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/60Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605Morus (mulberry)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/77Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815Lycium (desert-thorn)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8965Asparagus, e.g. garden asparagus or asparagus fern
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/302Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Definitions

  • the present invention relates to a composition for the prevention and treatment of menopausal syndrome and its use containing the extract of the combination herbal extract of baekchul, heartache, goji berry, longan meat, dew, tofu and astronomical dong as an active ingredient.
  • Menopause is an inevitable phenomenon in all women, but the resulting deficiency of female hormones is an important factor that causes physical and mental illness over a long period of time.
  • the so-called "menopausal syndrome” includes a variety of symptoms and diseases, which can be divided into early acute symptoms, mid-term symptoms and long-term sequelae, depending on the time of onset. Symptoms of early menopausal period include vasomotor symptoms such as febrile flushing and night sweats, as well as mental and psychological symptoms. Mid-term symptoms include symptoms of urogenital atrophy and symptoms caused by decreased collagen from connective tissue in each part of the body. This mid-term symptom, unlike the acute early symptom, which is of limited nature, takes a worse course as the menopause progresses.
  • the long-term sequelae of late stages of menopause include osteoporosis, cardiovascular and cerebrovascular diseases, and senile dementia belongs to this category.
  • the rate of menopausal symptoms among menopausal women in Korea ranged from 57% to 90% .
  • the range of symptoms experienced was neurological sensitivity, musculoskeletal symptoms, fatigue and systemic weakness, and headache. The frequency and intensity were high.
  • vasomotor symptoms such as hot flashes and sweating were reported to increase in the late 1990s than the 1980s.
  • 89% of women who experienced natural menopause experienced at least one of the symptoms of menopause, with 61% reported that hot flashes were the most common.
  • Hormone therapy is typically used to treat such female hormone regulation-related diseases or symptoms. However, hormone therapy has been shown to cause side effects such as breast cancer, stroke, heart attack, venous thrombosis, and cardiovascular disease. (Korean Patent No. 10-1400913)
  • Baekchul refers to the root of the perennial herb, Atractylodes macrocephala KOIDZ, and the related plant of the same genus, which contains essential oils, attractyllone, and attractyllol. , Arthritis, keratosis, urinary inflammation, etc. It is known to have been used (information interception, Dohae Hyangjeomsa, Yeonglimsa, pp1026, 1998).
  • the lettuce is a seed of the broad-leaved mulberry (Morus alba L.) belonging to the Moraceae family, and is related to sugar, tannic acid, linoloic acid, stearinic acid, etc. It contains a substance and is known to have been used for the treatment of thirst and joint bleeding (information disclosure, Dohae Hyangdae, Yeonglimsa, pp545-548, 1998).
  • Goji refers to the mature fruit of the vine shrub Lycium chinensis, Lycium barbarum L. belonging to the Solanaceae, and contains substances such as carotene, nicotinc acid, etc. It is known to have a blood sugar and cholesterol lowering effect, lowering blood pressure, etc. (Interpretation of Information, Dohae Hyangdae, Yeonglimsa, pp826-828, 1998).
  • Longan meat refers to the aphid of Euphoria lingan STEUD, an evergreen tree belonging to Sapinaceae. It contains substances such as glucose, sucrose and tartaric acid, and has been used to treat insomnia and forgetfulness. It is known to have been reported (Information Disclosure, Dohae Hyangjeomsa Dictionary, Younglim History, pp371-373, 1998).
  • the larvae refers to the bark of the Eucommia ulmoides OLIV, a broad-leaved arborescent, belonging to the Eucommiaceae family.
  • Astronomical dong is the tuber of Asparagus cochinchinensis MERR, a perennial herbaceous herb belonging to the Liliaceae family.
  • Antimicrobial activity, insecticidal action, anti-ulcer action are known (information disclosure, Dohaehyangsaemsa, Yeonglimsa, pp164-165, 1998).
  • Ginger refers to the root of Zingiber officinale ROSC, a perennial herb belonging to the family Zingiberaceae, and is known as zingiberol, zingiberone, phellandrene, gingerol, show It contains substances such as shogaol, and antibacterial and antiparasitic action is known (information disclosure, Dohae Hyangdae, Yeonglimsa, pp260-262, 1998).
  • Jujube refers to the fruit of Zizyphus jujubaMILL, a broad-leaved arborescent tree belonging to Rhamnaceae, and contains substances such as protein, organic acids, etc., and is known for strengthening muscles, protecting liver, and gaining weight. Sup-eup, Dohae Hyangjeomsa Dictionary, Younglim History, pp296-297, 1998).
  • the present inventors studied to find natural products that are excellent for improving menopausal syndrome, and the combination extract of the present invention measured the global skin ability evaluation test using tail mice in vivo, and the tail skin temperature.
  • the present invention was completed by confirming that the exercise time was increased, the increase in the tail skin temperature was suppressed, and the liver showed excellent menopausal symptoms improvement effect in clinical cases.
  • the present invention provides a pharmaceutical composition for treating and preventing menopausal syndrome, which contains a combination herbal extract consisting of baekchul, heartache, goji berry, longan meat, dew, tofu and astronomical dong as an active ingredient.
  • the present invention provides a health functional food for preventing and improving menopausal syndrome, which contains a combination herbal extract consisting of Baekchul, heartache, goji berry, longan meat, wort, tofu and astronomical dong as an active ingredient.
  • Combination herbal extracts as defined herein include water, including purified water, lower alcohols of C1 to C4 or mixed solvents thereof, preferably extracts available in water or mixed solvents of water and alcohol.
  • Combination herbal extracts as defined herein additionally include one or more herbal extracts consisting of ginger and jujube; At least one vitamin selected from the group consisting of vitamin A, vitamin E, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, biotin, nicotinamide, folic acid, and calcium pantothenate; And / or at least one mineral selected from the group consisting of ferrous sulfate, zinc oxide, magnesium carbonate, potassium monophosphate, dibasic calcium phosphate, potassium citrate, calcium carbonate, and magnesium chloride.
  • Preferred blending weight parts of the combination herbal extract as defined herein include (a) Baekchul 1, 10, beetle 1-10, Gojija 1 to 1 in the case of the combination of Baekchul, Wokjak, Gojija, Longan meat, dew, tofu and astronomical dong.
  • menopausal syndrome is preferably fatigue, febrile flushing, vasomotor symptoms, depression, anxiety, dizziness, headache, associated with changes in menopausal syndrome, more preferably sex hormones, before or after menopause or by disease. , Joint pain, muscle pain, osteoporosis, insomnia, vaginal dryness, and the symptoms or symptoms, including all or part of the syndrome.
  • the combination herbal extract of the present invention can be obtained as follows.
  • the herbal extract of the present invention is mixed with herbal medicines such as baekchul, sirloin, goji berry, longan meat, hyssop, tofu and astronomical dong, if necessary, ginger and jujube in a certain compounding ratio, and wash each combination sample with water. After drying, they are all ground and ground to a volume of water ranging from about 1 to 20 times, preferably about 2 to 10 times the weight of the herbal ingredient, C1 to C4 lower alcohol, or a mixed solvent thereof, preferably water.
  • herbal medicines such as baekchul, sirloin, goji berry, longan meat, hyssop, tofu and astronomical dong, if necessary, ginger and jujube in a certain compounding ratio
  • Extraction such as hot water extraction, cold extraction, reflux cooling extraction, ultrasonic extraction or supercritical extraction, for about 1 hour to 1 day, preferably 2 hours to 8 hours at a temperature of from 120 to 120 ° C., preferably from 20 to 100 ° C.
  • a hot water extraction method After extracting by a method, preferably a hot water extraction method, the extract is cooled and then filtered, and the filtrate is lyophilized to obtain the combination herbal extract of the present invention.
  • the present invention provides a health functional food for improving and preventing menopausal syndrome, which contains a combination herbal extract consisting of baekchul, sirloin, goji berry, yongan meat, dew, worm and cheonmundong as an active ingredient.
  • a combination herbal extract consisting of baekchul, sirloin, goji berry, yongan meat, dew, worm and cheonmundong as an active ingredient.
  • the extract as defined herein is a polar solvent selected from water, alcohol, lower alcohols having 1 to 4 carbon atoms or mixed solvents thereof, preferably water or water and alcohol mixed solvents, more preferably water or 20 to 90% water And extracts soluble in alcohol mixed solvents.
  • the present invention provides a pharmaceutical composition and health functional food for the treatment and prevention of menopausal syndrome containing the preparation method and the combination herbal extract prepared by the manufacturing method as an active ingredient.
  • the global movement ability and tail skin temperature were measured using the menopausal induced mice in vivo, and the experimental group to which the extracts of Examples 1 to 3 were administered was compared to the negative control group.
  • the experimental group to which the extracts of Examples 1 to 3 were administered was compared to the negative control group.
  • the present invention provides a menopausal syndrome improvement agent containing a combination herbal extract consisting of Baekchul, heartache, goji berry, longan meat, wedge, head worm and astronomical dong as an active ingredient.
  • composition of the present invention comprises 0.01 to 99% by weight of the herbal extract based on the total weight of the composition.
  • composition as described above is not necessarily limited thereto, and may vary according to the condition of the patient and the type and extent of the disease.
  • composition comprising the extract of the present invention may further comprise suitable carriers, excipients and diluents commonly used in the manufacture of pharmaceutical compositions.
  • compositions comprising extracts according to the invention are formulated in the form of powders, granules, tablets, capsules, suspensions, emulsions, syrups, aerosols and the like, oral preparations, suppositories and sterile injectable solutions, respectively, according to conventional methods.
  • the carriers, excipients and diluents that may be included in the formulation may include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acacia rubber, alginate, gelatin, calcium phosphate, calcium Silicates, cellulose, methyl cellulose, microcrystalline cellulose, polyvinyl pyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, magnesium stearate and mineral oil.
  • diluents or excipients such as fillers, extenders, binders, wetting agents, disintegrating agents, and surfactants are usually used.
  • Solid preparations for oral administration include tablets, pills, powders, granules, capsules, and the like, and such solid preparations include at least one or more excipients in the compound, at least cotton, starch, calcium carbonate, sucrose. Or lactose, gelatin, or the like is mixed. In addition to simple excipients, lubricants such as magnesium styrate talc are also used. Oral liquid preparations include suspending agents, liquid solutions, emulsions, and syrups, and may include various excipients, such as wetting agents, sweeteners, fragrances, and preservatives, in addition to commonly used simple diluents such as water and liquid paraffin. .
  • Formulations for parenteral administration include sterile aqueous solutions, non-aqueous solvents, suspensions, emulsions, lyophilized preparations, suppositories.
  • non-aqueous solvent and suspending agent propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate and the like can be used.
  • base of the suppository witepsol, macrogol, tween 61, cacao butter, laurin butter, glycerol gelatin and the like can be used.
  • Preferred dosages of the extracts of the present invention vary depending on the condition and weight of the patient, the extent of the disease, the form of the drug, the route of administration and the duration, and may be appropriately selected by those skilled in the art.
  • the extract is preferably administered at 0.01 mg / kg to 10 g / kg, preferably 1 mg / kg to 1 g / kg per day. Administration may be administered once a day or may be divided several times. Therefore, the above dosage does not limit the scope of the present invention in any aspect.
  • composition of the present invention can be administered to mammals such as rats, mice, livestock, humans, etc. by various routes. All modes of administration can be expected, for example by oral and rectal or intravenous methods.
  • the present invention provides a therapeutic method for treating a climacteric syndrome patient, comprising administering a combination herbal extract consisting of baekchul, heartache, goji berry, longan meat, wedge, head worm and astronomical dong to patients with menopausal syndrome.
  • the present invention provides the use of a combination herbal extract consisting of baekchul, heartache, gojija, longan meat, dew, head worm and astronomical dong for the manufacture of a medicament for treating menopausal syndrome.
  • the present invention provides a health functional food for the improvement and prevention of climacteric syndrome, which contains a combination herbal extract consisting of baekchul, sirloin, goji berry, longan meat, dew, tofu and cheonmundong as an active ingredient.
  • a combination herbal extract consisting of baekchul, sirloin, goji berry, longan meat, dew, tofu and cheonmundong as an active ingredient.
  • health functional food refers to physical or mental functionality by adding the extract of the present invention to a conventional specimen for preventing or ameliorating a target disease in a human body or a mammal according to Korean Health Functional Food Act No. 6723. It includes a functional food to improve the functionality such as.
  • the present invention provides a menopausal nutritional supplement containing a combination herbal extract consisting of Baekchul, heartache, goji berry, longan meat, dew, tofu and astronomical dong as an active ingredient.
  • a combination herbal extract consisting of Baekchul, heartache, goji berry, longan meat, dew, tofu and astronomical dong as an active ingredient.
  • Health functional foods containing the extract of the present invention can be used in a variety of drugs, foods and beverages for the improvement and prevention of menopausal syndrome.
  • Foods to which the extract of the present invention may be added include, for example, various foods, beverages, gums, teas, vitamin complexes, leach teas, health supplements, and the like, and are in the form of powders, granules, tablets, capsules, or beverages. Can be used.
  • the total weight of the composition comprises 0.01 to 95%, preferably 1 to 80% by weight percentage.
  • composition of the present invention can be used as a major component or additive and adjuvant in the manufacture of various dietary supplements and dietary supplements for the purpose of preventing or treating menopausal syndrome.
  • menopausal syndrome for the purpose of preventing and improving menopausal syndrome, it is prepared as a pharmaceutical dosage form such as powders, granules, tablets, capsules, pills, suspensions, emulsions, syrups, or health functional foods in the form of tea bags, leach teas, and health drinks. And processing is possible.
  • a pharmaceutical dosage form such as powders, granules, tablets, capsules, pills, suspensions, emulsions, syrups, or health functional foods in the form of tea bags, leach teas, and health drinks. And processing is possible.
  • the present invention also provides a food additive for improving and preventing fatigue syndrome, menopausal syndrome, containing a combination herbal extracts of Baekchul, heartache, goji berry, longan meat, dew, tofu and cheonmundong as an active ingredient.
  • Food forms to which the extract of the present invention can be added include various foods, beverages, gums, teas, vitamin complexes, or health supplements of candy.
  • the health beverage composition of the present invention contains a mixture of the extract as an essential ingredient in the indicated proportions, and there is no particular limitation on the liquid component, and may contain various flavors or natural carbohydrates as additional ingredients, such as ordinary drinks.
  • natural carbohydrates are conventional monosaccharides such as disaccharides such as glucose and fructose, such as maltose, sucrose and the like, and polysaccharides such as dextrin, cyclodextrin and the like.
  • Sugars and sugar alcohols such as xylitol, sorbitol, and erythritol.
  • natural flavoring agents such as, tauumatin, stevia extract (e.g., Rebaudioside A, glycyrrhizin, etc.) and synthetic flavoring agents (saccharin, aspartame, etc.) can be advantageously used.
  • the proportion of such natural carbohydrates is generally about 1 to 20 g, preferably about 5 to 12 g per 100 ml of the composition of the present invention.
  • the composition of the present invention includes various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, coloring and neutralizing agents (such as cheese and chocolate), pectic acid and salts thereof, alginic acid and its Salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated beverages, and the like.
  • the compositions of the present invention may also contain pulp for the production of natural fruit juices and fruit juice beverages and vegetable beverages. These components can be used independently or in combination. The proportion of such additives is not so critical but is generally selected from the range of 0 to about 20 parts by weight per 100 parts by weight of the composition of the present invention.
  • the extract of the present invention may be added to food or beverages for the purpose of preventing menopausal syndrome.
  • the amount of the extract in the food or beverage can be added in 0.01 to 15% by weight of the total food weight
  • the health beverage composition is added in a ratio of 0.02 to 5 g, preferably 0.3 to 1 g based on 100 ml Can be.
  • a combination extract can be used as a raw material for manufacturing health functional foods or supplements such as drugs for treating menopausal symptoms or menopausal nutritional supplements.
  • health functional foods or supplements such as drugs for treating menopausal symptoms or menopausal nutritional supplements.
  • F. It can be applied as a pharmaceutical composition, health functional food and health supplement food useful for suppressing, treating, preventing and improving menopausal syndrome.
  • the experiment was performed as follows in the menopausal animal model subjected to ovarian resection described in the literature.
  • mice Seven-week-old ICR mice (28-30 g) were supplied from Orient Bio Co., Ltd. (Seoul, Korea) and used in animal laboratories for about 5 days. The water and feed were freely consumed, and the temperature (23 ⁇ 2 °C), Humidity (50 ⁇ 10%) and contrast period (12 hours) were allowed to adjust automatically.
  • the samples of the present invention were administered orally in one dose group.
  • the control group (Sham) and negative control group (OVX + saline) were orally administered with saline.
  • After 2 weeks of administration weigh the mouse and measure the tail skin temperature before starting exercise. Place the mouse in the restrainer, stabilize for 5 minutes, and remove 1 cm from the base of the tail every 3 minutes.
  • the tail temperature was measured using a thermal imaging camera (FLIR T600, USA) (Basal temperature, T B ), followed by 10 minutes at 15 m / min on a treadmill (Exer-3 / 6, Columbus instruments, USA).
  • T B mean of three measurements of tail skin temperature before exercise
  • T E1 Tail skin temperature measurement 1 minute after exercise
  • T E2 Tail skin temperature measurement 2 minutes after exercise
  • the ovaries of the mice were excised and orally administered with the extracts of Examples 1 to 3 for 2 weeks, and the tail skin temperature was measured using a thermal imaging camera. .
  • Menopausal-induced mice were evaluated for the effects of menopausal fatigue by the extract administration of Examples 1 to 3 in the treadmill exercise experiment. Modify the method of Minghua et al. (Mechanisms of Ageing and Development, 2003, 124: 771) to raise the angle of the treadmill by 10 degrees, then start driving at 15 m / min, in steps of 5 m / min every three minutes. The speed was raised to a maximum of 30 m / min, and the time until the mouse became inoperable (maximum travel time) was measured.
  • Samples of the present invention exhibited excellent hot flush reduction effect in caudal skin test of climacteric-induced mice and showed excellent maximum running time even in climacteric antifatigue experiments. It is believed to improve or treat menopausal hot flush and menopausal fatigue.
  • Kupperman Index Symptom none slightly usually Severe One Flushing, hot, burning 0 4 8 12 2 Sweating 0 2 4 6 3 insomnia 0 2 4 6 4 nervousness 0 One 2 3 5 depression 0 One 2 3 6 whirl 0 One 2 3 7 Fatigue 0 One 2 3 8 Arthralgia, myalgia 0 One 2 3 9 headache 0 One 2 3 10 Heartbeat 0 One 2 3 11 Dryness 0 One 2 3
  • the above ingredients are mixed and filled in an airtight cloth to prepare a powder.
  • tablets are prepared by tableting according to a conventional method for preparing tablets.
  • the above ingredients are mixed and filled into gelatin capsules to prepare capsules.
  • the amount of the above ingredient is prepared per ampoule (2 ml).
  • composition ratio of the said vitamin and mineral mixture was mixed and comprised in the preferable embodiment the component suitable for a healthy food, you may change arbitrarily the compounding ratio considered that it does not deviate from the mind and range of this invention.
  • the resulting solution is filtered and obtained in a sterilized 2 L container, sealed sterilization and refrigerated Used to prepare the healthy beverage composition of the invention.
  • the combination extract can be used as a raw material for manufacturing health functional foods or supplements such as drugs for treating menopausal symptoms or menopausal nutritional supplements. It was found for the first time that it can be applied as pharmaceutical composition, health functional food and health supplement food which is useful for suppression, treatment, prevention and improvement of menopausal syndrome.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Botany (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a composition for treating and preventing climacteric syndrome, the composition containing a combined herbal medicinal extract of white atractylis, Mori fructus, Chinese matrimony vine, longan, Achyranthes, Eucommia bark, and Asparagus cochinchinensis Merr. as an active ingredient. The results of an endurance exercise ability evaluation test using a mouse and measurement of a hot flush alleviating effect using the tail skin temperature of a climacterium-induced mouse revealed that an experimental group administered with the extract is able to perform an endurance exercise for a longer period of time than a control group and that the increase in tail skin temperature is suppressed in the experimental group. Thus, it was confirmed that the extract has the effects of alleviating and treating climacteric symptoms, and the extract can be utilized as a raw material for producing a drug, a health functional food, and a heath supplement food.

Description

백출, 상심자, 구기자, 용안육, 우슬, 두충 및 천문동의 조합생약 추출물을 유효성분으로 함유하는 갱년기증후군의 치료 및 예방을 위한 조성물 및 이의 용도Composition and its use for the treatment and prevention of menopausal syndrome, which contains as extracts the extract of the combination herbal extracts of baekchul, heartache, goji berry, longan meat, hyssop, headworm and astronomical dong
본 발명은 백출, 상심자, 구기자, 용안육, 우슬, 두충 및 천문동의 조합생약 추출물을 유효성분으로 함유하는 갱년기증후군의 예방 및 치료용 조성물 및 이의 용도에 관한 것이다.The present invention relates to a composition for the prevention and treatment of menopausal syndrome and its use containing the extract of the combination herbal extract of baekchul, heartache, goji berry, longan meat, dew, tofu and astronomical dong as an active ingredient.
폐경은 모든 여성에서 나타나는 필연적 현상이기는 하나, 그로 인한 여성호르몬의 결핍은 장기간에 걸쳐 신체적, 정신적 질환을 유발하는 중요한 인자로 작용하게 된다. 소위 "폐경기 증후군(postmenopausal syndrome)"은 다양한 증상과 질환을 포함하는데, 발현 시기에 따라 초기의 급성 증상, 중기 증상 및 말기의 장기적 후유증으로 나누어 볼 수 있다. 갱년기 초기의 증상으로는 열성 홍조와 야간발한 등 혈관운동성 증상과 정신적, 심리적 증상이 있으며, 폐경 기간이 경과함에 따라 소실되는 제한적인 특성을 보인다. 중기 증상으로는 비뇨생식계 위축 증상과 신체 각 부위의 결체조직으로부터 교원질이 감소됨으로써 나타나는 증상 등을 들 수 있다. 이 중기 증상은 제한적 특성을 보이는 급성 초기 증상과는 달리 폐경기간이 경과함에 따라 더욱 악화하는 과정을 취한다.Menopause is an inevitable phenomenon in all women, but the resulting deficiency of female hormones is an important factor that causes physical and mental illness over a long period of time. The so-called "menopausal syndrome" includes a variety of symptoms and diseases, which can be divided into early acute symptoms, mid-term symptoms and long-term sequelae, depending on the time of onset. Symptoms of early menopausal period include vasomotor symptoms such as febrile flushing and night sweats, as well as mental and psychological symptoms. Mid-term symptoms include symptoms of urogenital atrophy and symptoms caused by decreased collagen from connective tissue in each part of the body. This mid-term symptom, unlike the acute early symptom, which is of limited nature, takes a worse course as the menopause progresses.
폐경기간이 매우 경과함에 따라 나타나는 말기의 장기적 후유증으로는 골다공증, 심혈관질환과 뇌혈관질환이 대표적 질환이며 노인성 치매 등이 이 범주에 속한다. The long-term sequelae of late stages of menopause include osteoporosis, cardiovascular and cerebrovascular diseases, and senile dementia belongs to this category.
1980년대 이후 국내에서 수행된 폐경 관련 증상을 파악한 연구결과에 의하면 우리나라 폐경기 여성의 폐경증상 경험률은 57%에서 90%에 이르며 경험하는 증상의 범위는 신경예민, 근골격계 증상, 피로 및 전신쇠약, 두통의 빈도와 강도가 높게 나타났다. 폐경 증상 중 안면홍조, 발한 등의 혈관운동증상은 1980년대 보고율보다 1990년대 후반 연구에서 증상 호소율이 증가되는 것으로 보고되었다. 2000년대 연구에서도 자연폐경을 경험한 여성의 89%가 폐경 증상 중 적어도 하나를 경험하며, 안면홍조가 61%로 가장 흔한 것으로 보고되었다. According to the study of menopause-related symptoms performed in Korea since the 1980s, the rate of menopausal symptoms among menopausal women in Korea ranged from 57% to 90% .The range of symptoms experienced was neurological sensitivity, musculoskeletal symptoms, fatigue and systemic weakness, and headache. The frequency and intensity were high. Among the menopausal symptoms, vasomotor symptoms such as hot flashes and sweating were reported to increase in the late 1990s than the 1980s. In the 2000s, 89% of women who experienced natural menopause experienced at least one of the symptoms of menopause, with 61% reported that hot flashes were the most common.
이와 같은 여성 호르몬 조절 관련 질환 또는 증상을 치료하기 위해 대표적으로 호르몬 요법이 쓰이고 있다. 그러나 호르몬 요법은 유방암, 뇌졸중, 심장마비, 정맥 혈전증, 심혈관계 질환 등의 부작용을 일으킬 수 있는 것으로 나타났다. (한국 등록특허 10-1400913호)Hormone therapy is typically used to treat such female hormone regulation-related diseases or symptoms. However, hormone therapy has been shown to cause side effects such as breast cancer, stroke, heart attack, venous thrombosis, and cardiovascular disease. (Korean Patent No. 10-1400913)
이러한 호르몬 요법에 의한 문제점을 극복하기 위하여 천연 생약을 주성분으로 하는 여성 갱년기 증상의 개선제의 개발이 시도되고 있다.In order to overcome the problems caused by the hormone therapy, the development of women's menopausal symptoms improver based on natural herbal medicine has been attempted.
백출은 국화과 (Compositae)에 속하는 다년생 초본인 큰꽃삽주 (Atractylodes macrocephala KOIDZ) 및 동속 근연식물의 근경을 칭하는 것으로 정유, 아트락틸론(Atractylone), 아트락티롤(Atractylol) 등의 물질을 함유하고 있으며, 관절염, 각기증, 소변불리 등의 치료에 사용해온 것으로 알려져 있다 (정보섭외, 도해향약대사전, 영림사, pp1026, 1998). Baekchul refers to the root of the perennial herb, Atractylodes macrocephala KOIDZ, and the related plant of the same genus, which contains essential oils, attractyllone, and attractyllol. , Arthritis, keratosis, urinary inflammation, etc. It is known to have been used (information interception, Dohae Hyangjeomsa, Yeonglimsa, pp1026, 1998).
상심자는 뽕나무과 (Moraceae)에 속하는 활엽교목인 뽕나무(Morus alba L.)의 및 동속 근연식물의 종자를 칭하는 것으로 당분, 탄닌산(tannic acid), 리놀산(linoloic acid), 스테아린산 (stearinic acid), 등의 물질을 함유하고 있으며, 소갈증, 관절불리 등의 치료에 사용해온 것으로 알려져 있다 (정보섭외, 도해향약대사전, 영림사, pp545-548, 1998). The lettuce is a seed of the broad-leaved mulberry (Morus alba L.) belonging to the Moraceae family, and is related to sugar, tannic acid, linoloic acid, stearinic acid, etc. It contains a substance and is known to have been used for the treatment of thirst and joint bleeding (information disclosure, Dohae Hyangdae, Yeonglimsa, pp545-548, 1998).
구기자는 가지과 (Solanaceae)에 속하는 덩굴성 관목인 구기자나무 (Lycium chinensis), 영하구기자(Lycium barbarum L.)의 성숙한 과실을 칭하는 것으로 카로텐(carotene), 니코틴산(nicotinc acid), 등의 물질을 함유하고 있으며, 혈당 및 콜리스테롤 강하작용, 혈압저하작용 등을 갖는 것으로 알려져 있다 (정보섭외, 도해향약대사전, 영림사, pp826-828, 1998). Goji refers to the mature fruit of the vine shrub Lycium chinensis, Lycium barbarum L. belonging to the Solanaceae, and contains substances such as carotene, nicotinc acid, etc. It is known to have a blood sugar and cholesterol lowering effect, lowering blood pressure, etc. (Interpretation of Information, Dohae Hyangdae, Yeonglimsa, pp826-828, 1998).
용안육은 무환자나무과 (Sapinaceae)에 속하는 상록교목인 용안 (Euphoria lingan STEUD)의 가종피(假種皮)를 칭하는 것으로 포도당, 서당, 주석산 등의 물질을 함유하고 있으며, 불면, 건망증 등의 치료에 사용해온 것으로 알려져 있다 (정보섭외, 도해향약대사전, 영림사, pp371-373, 1998). Longan meat refers to the aphid of Euphoria lingan STEUD, an evergreen tree belonging to Sapinaceae. It contains substances such as glucose, sucrose and tartaric acid, and has been used to treat insomnia and forgetfulness. It is known to have been reported (Information Disclosure, Dohae Hyangjeomsa Dictionary, Younglim History, pp371-373, 1998).
우슬은 비름과 (Amaranthaceae)에 속하는 다년생 초본인 쇠무릎 (Achyranthus japonica NAKAI) 혹은 우슬 (Acyranthes bidentata Blume)의 근을 칭하는 것으로 트리테르페노이드 사포닌 (triterpeoid saponin), 엑디스테론(ecdysterone), 이노코스테론(inokosterone) 등의 물질을 함유하고 있으며, 자궁수축작용, 혈압강하작용, 진통작용 등의 치료에 사용해온 것으로 알려져 있다 (정보섭외, 도해향약대사전, 영림사, pp340-342, 1998). It is the root of the perennial herb, Achyranthus japonica NAKAI, or Acyranthes bidentata Blume, which belongs to the Amaranthaceae. It contains substances such as (inokosterone), and is known to have been used for the treatment of uterine contraction, blood pressure lowering, analgesic, etc. (Interpretation of Information, Doha Hyangje Dictionary, Younglimsa, pp340-342, 1998).
두충은 두충과 (Eucommiaceae)에 속하는 활엽교목인 두충나무 (Eucommia ulmoides OLIV)의 수피를 칭하는 것으로 구타-페르카(gutta-percha), 알칼로이드(alkaloid), 펙틴(pectin), 케토스(ketose), 리놀산 (linoleic aicd) 등의 물질을 함유하고 있으며, 혈압강하작용, 이뇨작용 등이 알려져 있다 (정보섭외, 도해향약대사전, 영림사, pp605-606, 1998). The larvae refers to the bark of the Eucommia ulmoides OLIV, a broad-leaved arborescent, belonging to the Eucommiaceae family. Gutta-percha, alkaloid, pectin, ketose, It contains substances such as linoleic aicd, and it is known to lower blood pressure and diuretic effect (information consultation, Dohae medicine pharmacy dictionary, Yeonglimsa, pp605-606, 1998).
천문동은 백합과 (Liliaceae)에 속하는 다년성 덩굴성 초본인 천문동 (Asparagus cochinchinensis MERR)의 괴경을 칭하는 것으로 아스파라긴(asparagine), 점액질, 시토스테롤 (sitosterol), 스밀라게닌(smilagenin) 등의 물질을 함유하고 있으며, 항균작용, 살충작용, 항궤양작용 등이 알려져 있다 (정보섭외, 도해향약대사전, 영림사, pp164-165, 1998). Astronomical dong is the tuber of Asparagus cochinchinensis MERR, a perennial herbaceous herb belonging to the Liliaceae family. , Antimicrobial activity, insecticidal action, anti-ulcer action are known (information disclosure, Dohaehyangsaemsa, Yeonglimsa, pp164-165, 1998).
생강은 생강과 (Zingiberaceae)에 속하는 다년성 초본인 생강 (Zingiber officinale ROSC)의 근경을 칭하는 것으로 징기베롤(zingiberol), 징기베론(zingiberone), 펠란드렌(phellandrene), 진저롤(gingerol), 쇼가올(shogaol), 등의 물질을 함유하고 있으며, 항균 및 항기생충 작용 등이 알려져 있다 (정보섭외, 도해향약대사전, 영림사, pp260-262, 1998). Ginger refers to the root of Zingiber officinale ROSC, a perennial herb belonging to the family Zingiberaceae, and is known as zingiberol, zingiberone, phellandrene, gingerol, show It contains substances such as shogaol, and antibacterial and antiparasitic action is known (information disclosure, Dohae Hyangdae, Yeonglimsa, pp260-262, 1998).
대추는 갈매나무과 (Rhamnaceae)에 속하는 활엽교목인 대추나무 (Zizyphus jujubaMILL)의 과실을 칭하는 것으로 단백질, 유기산, 등의 물질을 함유하고 있으며, 근육강화, 간장보호, 체중증가 작용 등이 알려져 있다 (정보섭외, 도해향약대사전, 영림사, pp296-297, 1998). Jujube refers to the fruit of Zizyphus jujubaMILL, a broad-leaved arborescent tree belonging to Rhamnaceae, and contains substances such as protein, organic acids, etc., and is known for strengthening muscles, protecting liver, and gaining weight. Sup-eup, Dohae Hyangjeomsa Dictionary, Younglim History, pp296-297, 1998).
그러나, 상기 문헌의 어디에도 백출, 상심자, 구기자, 용안육, 우슬, 두충 및 천문동의 조합생약을 유효성분으로 함유하는 갱년기증후군 혹은 유사증상에 대한 예방, 억제, 개선, 혹은 치료에 대하여 개시되거나 교시된 바가 없다. However, none of the above documents discloses or teaches the prevention, suppression, amelioration, or treatment of climacteric syndrome or similar symptoms containing a combination of medicinal herbs such as baekrye, heartache, goji berry, yong'an meat, loin, tofu and astronomical dong as an active ingredient. There is no bar.
이에 따라, 본 발명자는 갱년기증후군의 개선에 탁월한 천연물을 찾고자 연구하였고 본 발명의 조합 추출물이 in vivo상 마우스를 이용한 지구적 운동능력 평가실험, 꼬리피부온도를 측정한 바, 실험군이 대조군에 비하여 지구적 운동시간이 증가하고, 꼬리피부온도의 상승이 억제되며, 간이 임상예에서 탁월한 갱년기 증상 개선효과를 나타냄을 확인함으로서 본 발명을 완성하였다. Accordingly, the present inventors studied to find natural products that are excellent for improving menopausal syndrome, and the combination extract of the present invention measured the global skin ability evaluation test using tail mice in vivo, and the tail skin temperature. The present invention was completed by confirming that the exercise time was increased, the increase in the tail skin temperature was suppressed, and the liver showed excellent menopausal symptoms improvement effect in clinical cases.
본 발명자는 갱년기증후군의 개선에 보다 탁월한 천연물 치료제 개발을 기술적 과제로 한다. MEANS TO SOLVE THE PROBLEM The present inventors have made a technical task to develop the natural product therapeutic agent which is more excellent in the improvement of a menopausal syndrome.
상기 목적을 해결하기 위해 본 발명은 백출, 상심자, 구기자, 용안육, 우슬, 두충 및 천문동으로 구성된 조합생약 추출물을 유효성분으로 함유하는 갱년기증후군의 치료 및 예방용 약학조성물을 제공한다. In order to solve the above object, the present invention provides a pharmaceutical composition for treating and preventing menopausal syndrome, which contains a combination herbal extract consisting of baekchul, heartache, goji berry, longan meat, dew, tofu and astronomical dong as an active ingredient.
또한, 본 발명은 백출, 상심자, 구기자, 용안육, 우슬, 두충 및 천문동으로 구성된 조합생약 추출물을 유효성분으로 함유하는 갱년기증후군의 예방 및 개선용 건강기능식품을 제공한다.In another aspect, the present invention provides a health functional food for preventing and improving menopausal syndrome, which contains a combination herbal extract consisting of Baekchul, heartache, goji berry, longan meat, wort, tofu and astronomical dong as an active ingredient.
본원에서 정의되는 조합생약 추출물은 정제수를 포함한 물, C1 내지 C4의 저급알코올 또는 이들의 혼합용매, 바람직하게는 물 또는 물 및 알콜 혼합용매에 가용한 추출물을 포함한다.Combination herbal extracts as defined herein include water, including purified water, lower alcohols of C1 to C4 or mixed solvents thereof, preferably extracts available in water or mixed solvents of water and alcohol.
본원에서 정의되는 조합생약 추출물은 추가적으로, 생강 및 대추로 구성된 하나 이상의 생약 추출물; 비타민 A, 비타민 E, 비타민 B1, 비타민 B2, 비타민 B6, 비타민 B12, 비타민 C, 비오틴, 니코틴산아미드, 엽산, 및 판토텐산 칼슘으로부터 구성된 군으로부터 선택된 하나 이상의 비타민류; 및/또는 황산 제1철, 산화아연, 탄산마그네슘, 제1인산칼륨, 제2인산칼슘, 구연산 칼륨, 탄산칼슘, 및 염화마그네슘으로부터 구성된 군으로부터 선택된 하나 이상의 무기질을 포함함을 특징으로 한다.Combination herbal extracts as defined herein additionally include one or more herbal extracts consisting of ginger and jujube; At least one vitamin selected from the group consisting of vitamin A, vitamin E, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, biotin, nicotinamide, folic acid, and calcium pantothenate; And / or at least one mineral selected from the group consisting of ferrous sulfate, zinc oxide, magnesium carbonate, potassium monophosphate, dibasic calcium phosphate, potassium citrate, calcium carbonate, and magnesium chloride.
본원에서 정의되는 조합생약 추출물의 바람직한 배합 중량부로는 (a) 백출, 상심자, 구기자, 용안육, 우슬, 두충 및 천문동의 조합인 경우는, 백출 1 내지 10, 상심자 1 내지 10, 구기자 1 내지 10, 용안육 1 내지 10, 우슬 1 내지 10, 두충 1 내지 10, 및 천문동 1 내지 10의 중량부(w/w), 보다 바람직하게는 백출 1 내지 5, 상심자 1 내지 5, 구기자 1 내지 5, 용안육 1 내지 5, 우슬 1 내지 5, 두충 1 내지 5 및 천문동 1 내지 5의 중량부(w/w), 보다 더 바람직하게는 백출 1 내지 3, 상심자 1 내지 3, 구기자 1 내지 3, 용안육 1 내지 3, 우슬 1 내지 3, 두충 1 내지 3 및 천문동 1 내지 3의 중량부(w/w),로 배합된 조합을 포함하며; (b) 백출, 상심자, 구기자, 용안육, 우슬, 두충, 천문동, 생강 및 대추의 조합인 경우는, 백출 1 내지 10, 상심자 1 내지 10, 구기자 1 내지 10, 용안육 1 내지 10, 우슬 1 내지 10, 두충 1 내지 10, 천문동 1 내지 10, 생강 1 내지 10 및 대추 1 내지 10의 중량부(w/w), 보다 바람직하게는 백출 1 내지 5, 상심자 1 내지 5, 구기자 1 내지 5, 용안육 1 내지 5, 우슬 1 내지 5, 두충 1 내지 5, 천문동 1 내지 5, 생강 1 내지 5 및 대추 1 내지 5의 중량부(w/w), 보다 더 바람직하게는 백출 1 내지 3, 상심자 1 내지 3, 구기자 1 내지 3, 용안육 1 내지 3, 우슬 1 내지 3, 두충 1 내지 3, 천문동 1 내지 3, 생강 1 내지 2 및 대추 1 내지 2의 중량부(w/w)로 배합된 조합을 포함함을 특징으로 한다.Preferred blending weight parts of the combination herbal extract as defined herein include (a) Baekchul 1, 10, beetle 1-10, Gojija 1 to 1 in the case of the combination of Baekchul, Wokjak, Gojija, Longan meat, dew, tofu and astronomical dong. 10, longan meat 1 to 10, waddle 1 to 10, tofu 1 to 10, and 1 to 10 parts by weight of astronomical dong (w / w), more preferably Baekchul 1 to 5, heart 1 to 5, wolfberry 1 to 5 , Yongan 1 to 5, dew 1 to 5, tortoise 1 to 5 and astronomical dong 1 to 5 parts by weight (w / w), even more preferably white 1 to 3, heart 1 to 3, wolfberry 1 to 3, A combination of formulated in parts by weight (w / w) of 1 to 3 of longeye, 1 to 3 of wedges, 1 to 3 of worms and 1 to 3 of astronomical dong; (b) If the combination of baekchul, sirloin, wolfberry, longan, beef, bean curd, astronomical dong, ginger and jujube, baekchul 1-10, beetle 1-10, wolfberry 1-10, yongan 1-10, dew 1 To 10, tofu 1 to 10, astronomical dong 1 to 10, ginger 1 to 10 and jujube 1 to 10 parts by weight (w / w), more preferably white 1 to 5, heart 1 to 5, wolfberry 1 to 5 , Yongan 1-5, dew 1-5, tofu 1-5, astronomical 1-5, ginger 1-5 and jujube 1-5 parts by weight (w / w), even more preferably Baekchul 1-3, 1 to 3, wolfberry 1 to 3, yongan 1 to 3, wort 1 to 3, tofu 1 to 3, astronomical 1 to 3, ginger 1 to 2 and jujube 1 to 2 parts by weight (w / w) of Combinations.
본원에서 정의되는 “갱년기 증후군”은 바람직하게는, 폐경기 전후 혹은 질환에 의한 갱년기증후군, 보다 바람직하게는, 성호르몬의 변화와 연관된, 피로, 열성홍조, 혈관운동증상, 우울, 불안, 어지러움, 두통, 관절통, 근육통, 골다공증, 불면, 질건조증 등의 증상이나 징후 중 전부 혹은 일부를 포함함을 특징으로 하는 증후군이다.As defined herein, “menopausal syndrome” is preferably fatigue, febrile flushing, vasomotor symptoms, depression, anxiety, dizziness, headache, associated with changes in menopausal syndrome, more preferably sex hormones, before or after menopause or by disease. , Joint pain, muscle pain, osteoporosis, insomnia, vaginal dryness, and the symptoms or symptoms, including all or part of the syndrome.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명의 조합생약 추출물은 하기와 같이 수득될 수 있다.The combination herbal extract of the present invention can be obtained as follows.
본 발명의 조합생약 추출물은 생약 재료인 백출, 상심자, 구기자, 용안육, 우슬, 두충 및 천문동, 필요시, 생강, 대추를 추가한 조합생약을 일정 배합비로 혼합하여, 이 조합 시료를 각각 물로 세척하여 음건 후, 모두 마쇄하여 상기 생약재료 중량의 약 1내지 20배, 바람직하게는 약 2내지 10배에 달하는 부피의 물, C1 내지 C4의 저급알코올 또는 이들의 혼합용매, 바람직하게는 물로, 0 내지 120℃ 온도, 바람직하게는 20 내지 100℃ 온도에서 약 1시간 내지 1일, 바람직하게는 2시간 내지 8시간 동안, 열수 추출, 냉침 추출, 환류 냉각 추출, 초음파 추출 또는 초임계 추출 등의 추출방법, 바람직하게는 열수추출방법으로 추출한 후, 추출액을 냉각 후에 여과하고 여과액을 동결 건조하여 본 발명의 조합생약 추출물을 얻을 수 있다.The herbal extract of the present invention is mixed with herbal medicines such as baekchul, sirloin, goji berry, longan meat, hyssop, tofu and astronomical dong, if necessary, ginger and jujube in a certain compounding ratio, and wash each combination sample with water. After drying, they are all ground and ground to a volume of water ranging from about 1 to 20 times, preferably about 2 to 10 times the weight of the herbal ingredient, C1 to C4 lower alcohol, or a mixed solvent thereof, preferably water. Extraction, such as hot water extraction, cold extraction, reflux cooling extraction, ultrasonic extraction or supercritical extraction, for about 1 hour to 1 day, preferably 2 hours to 8 hours at a temperature of from 120 to 120 ° C., preferably from 20 to 100 ° C. After extracting by a method, preferably a hot water extraction method, the extract is cooled and then filtered, and the filtrate is lyophilized to obtain the combination herbal extract of the present invention.
또한 본 발명은 백출, 상심자, 구기자, 용안육, 우슬, 두충 및 천문동으로 구성된 조합생약 추출물을 유효성분으로 함유하는 갱년기증후군의 개선 및 예방용 건강기능식품을 제공한다. In another aspect, the present invention provides a health functional food for improving and preventing menopausal syndrome, which contains a combination herbal extract consisting of baekchul, sirloin, goji berry, yongan meat, dew, worm and cheonmundong as an active ingredient.
본원에서 정의되는 상기 추출물은 물, 주정, 탄소수 1 내지 4의 저급알코올 또는 이들의 혼합용매로부터 선택된 극성용매, 바람직하게는 물 또는 물 및 주정 혼합용매, 보다 바람직하게는 물 또는 20 내지 90% 물 및 주정 혼합용매에 가용한 추출물을 포함한다.The extract as defined herein is a polar solvent selected from water, alcohol, lower alcohols having 1 to 4 carbon atoms or mixed solvents thereof, preferably water or water and alcohol mixed solvents, more preferably water or 20 to 90% water And extracts soluble in alcohol mixed solvents.
또한 본 발명은 상기 제조방법 및 상기 제조방법으로 제조된 조합생약 추출물을 유효성분으로 함유하는 갱년기증후군의 치료 및 예방을 위한 약학 조성물 및 건강기능식품을 제공한다. In another aspect, the present invention provides a pharmaceutical composition and health functional food for the treatment and prevention of menopausal syndrome containing the preparation method and the combination herbal extract prepared by the manufacturing method as an active ingredient.
상기에서 제조된 조합생약 추출물을 대상으로 in vivo상 갱년기 유발 마우스를 이용하여 지구적 운동능력과 꼬리 피부 온도를 측정하여, 실시예 1~3의 추출물을 투여한 실험군이 음성대조군에 비하여 지구적 운동시간이 증가하고, 꼬리피부온도의 상승이 억제되며, 간이 임상예에서 탁월한 갱년기 증상 개선효과를 나타냄을 확인함으로써, 갱년기증후군 예방 및 치료용 약제, 갱년기 영양보충제 등등 건강보조식품, 건강기능식품을 제조하는 원료로 조합 추출물을 활용할 수 있음을 처음으로 발견한 바, 갱년기증후군에 대한 억제, 예방 및 치료에 유용함을 밝혀냈다.Using the combined herbal extracts prepared above, the global movement ability and tail skin temperature were measured using the menopausal induced mice in vivo, and the experimental group to which the extracts of Examples 1 to 3 were administered was compared to the negative control group. By increasing the time, suppressing the increase of the tail skin temperature, and confirming the excellent effect of improving menopausal symptoms in the simple clinical cases, manufacturing health supplement foods, health functional foods, etc. for preventing and treating menopausal syndrome, menopausal nutritional supplements, etc. The first discovery that a combination extract can be used as a raw material to prove that it is useful for suppressing, preventing and treating menopausal syndrome.
따라서, 본 발명은 백출, 상심자, 구기자, 용안육, 우슬, 두충 및 천문동으로 구성된 조합생약 추출물을 유효성분으로 함유하는 갱년기증후군 개선제를 제공한다. Accordingly, the present invention provides a menopausal syndrome improvement agent containing a combination herbal extract consisting of Baekchul, heartache, goji berry, longan meat, wedge, head worm and astronomical dong as an active ingredient.
본 발명의 조성물은, 조성물 총 중량에 대하여 상기 생약 추출물을 0.01 내지 99% 중량으로 포함한다.The composition of the present invention comprises 0.01 to 99% by weight of the herbal extract based on the total weight of the composition.
그러나 상기와 같은 조성은 반드시 이에 한정되는 것은 아니고, 환자의 상태 및 질환의 종류 및 진행 정도에 따라 변할 수 있다.However, the composition as described above is not necessarily limited thereto, and may vary according to the condition of the patient and the type and extent of the disease.
본 발명의 추출물을 포함하는 조성물은 약학적 조성물의 제조에 통상적으로 사용하는 적절한 담체, 부형제 및 희석제를 더 포함할 수 있다.The composition comprising the extract of the present invention may further comprise suitable carriers, excipients and diluents commonly used in the manufacture of pharmaceutical compositions.
본 발명에 따른 추출물을 포함하는 조성물은, 각각 통상의 방법에 따라 산제, 과립제, 정제, 캡슐제, 현탁액, 에멀젼, 시럽, 에어로졸 등의 경구형 제형, 외용제, 좌제 및 멸균 주사용액의 형태로 제형화하여 사용될 수 있으며, 이에 포함될 수 있는 담체, 부형제 및 희석제로는 락토즈, 덱스트로즈, 수크로스, 솔비톨, 만니톨, 자일리톨, 에리스리톨, 말티톨, 전분, 아카시아 고무, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 셀룰로즈, 메틸 셀룰로즈, 미정질 셀룰로스, 폴리비닐 피롤리돈, 물, 메틸히드록시벤조에이트, 프로필히드록시벤조에이트, 마그네슘 스테아레이트 및 광물유를 들 수 있다. 제제화할 경우에는 보통 사용하는 충진제, 증량제, 결합제, 습윤제, 붕해제, 계면활성제 등의 희석제 또는 부형제를 사용하여 조제된다. 경구투여를 위한 고형제제에는 정제, 환제, 산제, 과립제, 캡슐제 등이 포함되며, 이러한 고형제제는 상기 화합물에 적어도 하나 이상의 부형제 적어도 면, 전분, 칼슘카보네이트(calcium carbonate), 수크로스(sucrose) 또는 락토오스(lactose), 젤라틴 등을 섞어 조제된다. 또한 단순한 부형제 이외에 마그네슘 스티레이트 탈크 같은 윤활제들도 사용된다. 경구를 위한 액상제제로는 현탁제, 내용액제, 유제, 시럽제 등이 해당되는데 흔히 사용되는 단순희석제인 물, 리퀴드 파라핀 이외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다. 비경구 투여를 위한 제제에는 멸균된 수용액, 비수성용제, 현탁제, 유제, 동결건조제제, 좌제가 포함된다. 비수성용제, 현탁제로는 프로필렌글리콜(propylene glycol), 폴리에틸렌 글리콜, 올리브 오일과 같은 식물성 기름, 에틸올레이트와 같은 주사 가능한 에스테르 등이 사용될 수 있다. 좌제의 기제로는 위텝솔(witepsol), 마크로골, 트윈(tween) 61, 카카오지, 라우린지, 글리세롤젤라틴 등이 사용될 수 있다.Compositions comprising extracts according to the invention are formulated in the form of powders, granules, tablets, capsules, suspensions, emulsions, syrups, aerosols and the like, oral preparations, suppositories and sterile injectable solutions, respectively, according to conventional methods. The carriers, excipients and diluents that may be included in the formulation may include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acacia rubber, alginate, gelatin, calcium phosphate, calcium Silicates, cellulose, methyl cellulose, microcrystalline cellulose, polyvinyl pyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, magnesium stearate and mineral oil. When formulated, diluents or excipients such as fillers, extenders, binders, wetting agents, disintegrating agents, and surfactants are usually used. Solid preparations for oral administration include tablets, pills, powders, granules, capsules, and the like, and such solid preparations include at least one or more excipients in the compound, at least cotton, starch, calcium carbonate, sucrose. Or lactose, gelatin, or the like is mixed. In addition to simple excipients, lubricants such as magnesium styrate talc are also used. Oral liquid preparations include suspending agents, liquid solutions, emulsions, and syrups, and may include various excipients, such as wetting agents, sweeteners, fragrances, and preservatives, in addition to commonly used simple diluents such as water and liquid paraffin. . Formulations for parenteral administration include sterile aqueous solutions, non-aqueous solvents, suspensions, emulsions, lyophilized preparations, suppositories. As the non-aqueous solvent and suspending agent, propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate and the like can be used. As the base of the suppository, witepsol, macrogol, tween 61, cacao butter, laurin butter, glycerol gelatin and the like can be used.
본 발명의 추출물의 바람직한 투여량은 환자의 상태 및 체중, 질병의 정도, 약물형태, 투여경로 및 기간에 따라 다르지만, 당업자에 의해 적절하게 선택될 수 있다. 그러나 바람직한 효과를 위해서, 추출물은 1일 0.01 mg/kg 내지 10 g/kg으로, 바람직하게는 1 mg/kg 내지 1 g/kg으로 투여하는 것이 좋다. 투여는 하루에 한번 투여할 수도 있고, 수회 나누어 투여할 수 있다. 그러므로 상기 투여량은 어떠한 면으로든 본 발명의 범위를 한정하는 것은 아니다.Preferred dosages of the extracts of the present invention vary depending on the condition and weight of the patient, the extent of the disease, the form of the drug, the route of administration and the duration, and may be appropriately selected by those skilled in the art. However, for the desired effect, the extract is preferably administered at 0.01 mg / kg to 10 g / kg, preferably 1 mg / kg to 1 g / kg per day. Administration may be administered once a day or may be divided several times. Therefore, the above dosage does not limit the scope of the present invention in any aspect.
본 발명의 조성물은 쥐, 생쥐, 가축, 인간 등의 포유동물에 다양한 경로로 투여될 수 있다. 투여의 모든 방식은 예상될 수 있는데, 예를 들면, 경구 및 직장 또는 정맥등의 방법을 통하여 투여 할 수 있다. The composition of the present invention can be administered to mammals such as rats, mice, livestock, humans, etc. by various routes. All modes of administration can be expected, for example by oral and rectal or intravenous methods.
또한 본 발명은 백출, 상심자, 구기자, 용안육, 우슬, 두충 및 천문동으로 구성된 조합생약 추출물을 갱년기증후군 환자에게 투여함을 포함하는, 갱년기증후군 환자를 치료하기 위한 치료방법을 제공한다. In another aspect, the present invention provides a therapeutic method for treating a climacteric syndrome patient, comprising administering a combination herbal extract consisting of baekchul, heartache, goji berry, longan meat, wedge, head worm and astronomical dong to patients with menopausal syndrome.
또한 본 발명은 갱년기증후군 치료용 약제를 제조하기 위한 백출, 상심자, 구기자, 용안육, 우슬, 두충 및 천문동으로 구성된 조합생약 추출물의 용도를 제공한다. In another aspect, the present invention provides the use of a combination herbal extract consisting of baekchul, heartache, gojija, longan meat, dew, head worm and astronomical dong for the manufacture of a medicament for treating menopausal syndrome.
또한 본 발명은 백출, 상심자, 구기자, 용안육, 우슬, 두충 및 천문동으로 구성된 조합생약 추출물을 유효성분으로 함유하는 갱년기증후군의 개선 및 예방을 위한 건강기능식품을 제공한다. In another aspect, the present invention provides a health functional food for the improvement and prevention of climacteric syndrome, which contains a combination herbal extract consisting of baekchul, sirloin, goji berry, longan meat, dew, tofu and cheonmundong as an active ingredient.
본원에서 정의되는 "건강기능식품"은 대한민국 건강기능식품에 관한 법률 제6727호에 따른 인체 또는 포유동물에서 목적질환을 예방 또는 개선하기 위한 종래 시품에 본 발명의 추출물을 첨가함으로서 물리학적 또는 정신적 기능성과 같은 기능성을 향상시키는 기능성 식품을 포함한다. As defined herein, "health functional food" refers to physical or mental functionality by adding the extract of the present invention to a conventional specimen for preventing or ameliorating a target disease in a human body or a mammal according to Korean Health Functional Food Act No. 6723. It includes a functional food to improve the functionality such as.
또한, 본 발명은 백출, 상심자, 구기자, 용안육, 우슬, 두충 및 천문동으로 구성된 조합생약 추출물을 유효성분으로 함유하는 갱년기 영양보충제를 제공한다. In another aspect, the present invention provides a menopausal nutritional supplement containing a combination herbal extract consisting of Baekchul, heartache, goji berry, longan meat, dew, tofu and astronomical dong as an active ingredient.
본 발명의 추출물을 포함하는 건강기능식품은 갱년기증후군의 개선 및 예방을 위한 약제, 식품 및 음료 등에 다양하게 이용될 수 있다. 본 발명의 추출물을 첨가할 수 있는 식품으로는, 예를 들어, 각종 식품류, 음료, 껌, 차, 비타민 복합제, 침출차, 건강보조 식품류 등이 있고, 분말, 과립, 정제, 캡슐 또는 음료인 형태로 사용할 수 있다.Health functional foods containing the extract of the present invention can be used in a variety of drugs, foods and beverages for the improvement and prevention of menopausal syndrome. Foods to which the extract of the present invention may be added include, for example, various foods, beverages, gums, teas, vitamin complexes, leach teas, health supplements, and the like, and are in the form of powders, granules, tablets, capsules, or beverages. Can be used.
본 발명의 갱년기증후군의 예방 및 개선을 위한 건강기능식품은, 조성물 총 중량에 대하여 상기 추출물을 0.01 내지 95%, 바람직하게는 1 내지 80% 중량백분율로 포함한다.The dietary supplement for the prevention and improvement of the menopausal syndrome of the present invention, the total weight of the composition comprises 0.01 to 95%, preferably 1 to 80% by weight percentage.
더욱이, 본 발명의 조성물은 갱년기증후군의 예방 또는 치료를 목적으로 한 다양한 건강기능식품 및 건강보조식품 제조에 있어서 주요 구성요소 또는 첨가제 및 보조제로서 사용가능하다. Moreover, the composition of the present invention can be used as a major component or additive and adjuvant in the manufacture of various dietary supplements and dietary supplements for the purpose of preventing or treating menopausal syndrome.
또한, 갱년기증후군의 예방 및 개선을 위한 목적으로 산제, 과립제, 정제, 캡슐제, 환제, 현탁액, 에멀젼, 시럽 등의 약학 투여형태 또는 티백제, 침출차, 건강 음료 등의 형태인 건강기능식품으로 제조 및 가공이 가능하다.In addition, for the purpose of preventing and improving menopausal syndrome, it is prepared as a pharmaceutical dosage form such as powders, granules, tablets, capsules, pills, suspensions, emulsions, syrups, or health functional foods in the form of tea bags, leach teas, and health drinks. And processing is possible.
따라서 또한, 본 발명은 백출, 상심자, 구기자, 용안육, 우슬, 두충 및 천문동의 조합생약 추출물을 유효성분으로 함유하는 피로증후군, 갱년기증후군의 개선 및 예방용 식품첨가제를 제공한다.Therefore, the present invention also provides a food additive for improving and preventing fatigue syndrome, menopausal syndrome, containing a combination herbal extracts of Baekchul, heartache, goji berry, longan meat, dew, tofu and cheonmundong as an active ingredient.
본 발명의 추출물을 첨가 가능한 식품형태는 캔디류의 각종 식품류, 음료, 껌, 차, 비타민 복합제 또는 건강보조 식품류인 식품 등을 포함한다.Food forms to which the extract of the present invention can be added include various foods, beverages, gums, teas, vitamin complexes, or health supplements of candy.
본 발명의 건강 음료 조성물은 지시된 비율로 필수 성분으로서 상기 추출물의 혼합물을 함유하는 것 외에 액체성분에는 특별한 제한점은 없으며 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상술한 천연 탄수화물의 예는 모노사카라이드, 예를 들어, 포도당, 과당 등의 디사카라이드, 예를 들어 말토스, 슈크로스 등의 및 폴리사카라이드, 예를 들어 덱스트린, 시클로덱스트린 등과 같은 통상적인 당 및 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 상술한 것 이외의 향미제로서 천연 향미제(타우마틴, 스테비아 추출물(예를 들어 레바우디오시드 A, 글리시르히진등)) 및 합성 향미제(사카린, 아스파르탐 등)를 유리하게 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명의 조성물 100 ml당 일반적으로 약 1 내지 20 g, 바람직하게는 약 5 내지 12 g이다.The health beverage composition of the present invention contains a mixture of the extract as an essential ingredient in the indicated proportions, and there is no particular limitation on the liquid component, and may contain various flavors or natural carbohydrates as additional ingredients, such as ordinary drinks. have. Examples of the above-mentioned natural carbohydrates are conventional monosaccharides such as disaccharides such as glucose and fructose, such as maltose, sucrose and the like, and polysaccharides such as dextrin, cyclodextrin and the like. Sugars and sugar alcohols such as xylitol, sorbitol, and erythritol. As flavoring agents other than those mentioned above, natural flavoring agents (tauumatin, stevia extract (e.g., Rebaudioside A, glycyrrhizin, etc.) and synthetic flavoring agents (saccharin, aspartame, etc.) can be advantageously used. have. The proportion of such natural carbohydrates is generally about 1 to 20 g, preferably about 5 to 12 g per 100 ml of the composition of the present invention.
상기 외에 본 발명의 조성물은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산 음료에 사용되는 탄산화제 등을 함유할 수 있다. 그밖에 본 발명의 조성물들은 천연 과일 쥬스 및 과일 쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. 이러한 첨가제의 비율은 그렇게 중요하진 않지만 본 발명의 조성물 100 중량부 당 0 내지 약 20 중량부의 범위에서 선택되는 것이 일반적이다.In addition to the above, the composition of the present invention includes various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, coloring and neutralizing agents (such as cheese and chocolate), pectic acid and salts thereof, alginic acid and its Salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated beverages, and the like. The compositions of the present invention may also contain pulp for the production of natural fruit juices and fruit juice beverages and vegetable beverages. These components can be used independently or in combination. The proportion of such additives is not so critical but is generally selected from the range of 0 to about 20 parts by weight per 100 parts by weight of the composition of the present invention.
또한, 본 발명의 추출물은 갱년기증후군 예방 효과를 목적으로 식품 또는 음료에 첨가될 수 있다. 이 때, 식품 또는 음료 중의 상기 추출물의 양은 전체 식품 중량의 0.01 내지 15 중량%로 가할 수 있으며, 건강 음료 조성물은 100 ㎖을 기준으로 0.02 내지 5 g, 바람직하게는 0.3 내지 1 g의 비율로 가할 수 있다.In addition, the extract of the present invention may be added to food or beverages for the purpose of preventing menopausal syndrome. At this time, the amount of the extract in the food or beverage can be added in 0.01 to 15% by weight of the total food weight, the health beverage composition is added in a ratio of 0.02 to 5 g, preferably 0.3 to 1 g based on 100 ml Can be.
본 발명의 조합생약 추출물을 대상으로 한 in vivo상 마우스를 이용한 지구적 운동능력 평가실험, 꼬리피부온도를 측정한 바, 실험군이 대조군에 비하여 지구적 운동시간이 증가하고, 꼬리피부온도의 상승이 억제되며, 간이 임상예에서 탁월한 갱년기 증상 개선효과를 나타냄을 확인함으로서, 갱년기증상 치료용 약제 혹은 갱년기 영양보충제 등 건강기능식품 혹은 건강보조식품을 제조하는 원료로 조합 추출물을 활용할 수 있음을 처음으로 확인한 바, 갱년기증후군에 대한 억제, 치료, 예방 및 개선에 유용한 약학조성물, 건강기능식품 및 건강보조식품으로 응용할 수 있다. Global exercise capacity evaluation experiment using mice in vivo, using the combination herbal extract of the present invention, the tail skin temperature was measured, the experimental group increased the global exercise time and the increase of the tail skin temperature compared to the control group By confirming that the liver shows an excellent effect of improving menopausal symptoms in clinical cases, it is the first time that a combination extract can be used as a raw material for manufacturing health functional foods or supplements such as drugs for treating menopausal symptoms or menopausal nutritional supplements. F. It can be applied as a pharmaceutical composition, health functional food and health supplement food useful for suppressing, treating, preventing and improving menopausal syndrome.
당업자라면 다양한 변형 및 변이가 본 발명의 정신 또는 범위를 이탈하지 않는 범위에서 본 발명의 조성물, 용도 및 제조에 사용 가능함이 자명할 것이다.Those skilled in the art will appreciate that various modifications and variations can be used in the compositions, uses and preparations of the invention without departing from the spirit or scope of the invention.
본 발명의 하기 실시예에 의해 보다 상세히 설명하나, 본 발명의 어떠한 방법으로도 하기 실시예로 제한하고자 하지 않는 것으로 이해되어야 한다.Although described in more detail by the following examples of the present invention, it should be understood that they are not intended to be limited to the following examples in any way of the present invention.
..
단, 하기 실시예 및 실험예는 본 발명의 범위를 제한하지 않는 범위에서 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예 및 실험예에 의해 한정되는 것은 아니다.However, the following Examples and Experimental Examples are only illustrative in a range not limiting the scope of the present invention, the contents of the present invention is not limited by the following Examples and Experimental Examples.
실시예 1. 조합예 1 (CB1)의 제조Example 1 Preparation of Combination Example 1 (CB1)
옴니허브에서 구입한 건조 상태의 생약들을 일정 중량 배합비(백출 1.5, 상심자 1.5, 구기자 1.5, 용안육 2, 우슬 1, 두충 1, 천문동 1, 생강 0.5, 대추 0.5)로 배합한 배합물 중량의 20배 부피의 물을 첨가하고 100℃에서 5시간 동안 추출기(COSMOS660, 경서기계산업)로 환류추출 한 후 100 mesh의 여과망이 부착된 여과조를 이용하여 여과한 후 상등액을 감압 및 농축한 후에 동결 건조하여 조합생약 추출물을 수득하고 기타 성분을 일정 중량 배합비 { 칼슘(굴각칼슘 ㈜KMF) 0.3, 비타민 B1(독일 DSM) 0.003, 및 비타민 B2 0.001 (한국 BASF)}로 배합된 배합물을 추가하여 본 발명의 조합예 (CB1)을 수득하여 하기 실험의 시료로 사용하였다. Twenty times the weight of the formulation of dry herbs purchased from OmniHub with a certain weight compounding ratio: Baekchul 1.5, Loach 1.5, Gugija 1.5, Longan meat 2, Emulsion 1, Tofu 1, Astronomical Dong 1, Ginger 0.5, Jujube 0.5 After adding a volume of water and refluxing with a extractor (COSMOS660, Kyungseo Machinery Co., Ltd.) at 100 ° C. for 5 hours, the mixture was filtered using a filter tank equipped with a 100 mesh filter network, and the supernatant was decompressed and concentrated, followed by freeze drying. A crude extract was obtained and the other ingredients were added to the formulation by combining a certain weight ratio {calcium (KMF) 0.3, vitamin B1 (Germany DSM) 0.003, and vitamin B2 0.001 (Korea BASF)}. (CB1) was obtained and used as a sample for the following experiment.
실시예 2. 조합예 2 (CB2)의 제조Example 2. Preparation of Combination Example 2 (CB2)
옴니허브에서 구입한 건조 상태의 생약들을 일정 중량 배합비(백출 1.5, 상심자 1.5, 구기자 1.5, 용안육 2, 우슬 2, 두충 2, 천문동 2, 생강 0.5, 대추 0.5)로 배합한 배합물 중량의 20배 부피의 70% 에탄올을 첨가하고 100℃에서 5시간 동안 추출기(COSMOS660, 경서기계산업)로 환류추출 한 후 100 mesh의 여과망이 부착된 여과조를 이용하여 여과한 후 상등액을 감압 및 농축한 후에 동결 건조하여 본 발명의 조합예 (CB2)을 수득하여 하기 실험의 시료로 사용하였다. Twenty times the weight of the formulation of dry herbs purchased from OmniHub with a certain weight compounding ratio: Baekchul 1.5, Loach 1.5, Gugija 1.5, Longan Meat 2, Emulsion 2, Tofu 2, Astronomical Dong 2, Ginger 0.5, Jujube 0.5 After adding 70% of ethanol by volume and refluxing with a extractor (COSMOS660, Kyungseo Machinery Co., Ltd.) at 100 ° C. for 5 hours, it was filtered through a filter tank with a 100 mesh filter network, and the supernatant was decompressed and concentrated, followed by freeze drying. Was used as a sample for the following experiment.
실시예 3. 조합예 3 (CB3)의 제조Example 3. Preparation of Combination Example 3 (CB3)
옴니허브에서 구입한 건조 상태의 생약들을 일정 중량 배합비(백출 1.5, 상심자 1.5, 구기자 1.5, 용안육 2, 우슬 1, 두충 1, 천문동 1)로 배합한 배합물 중량의 20배 부피의 물을 첨가하고 100℃에서 5시간 동안 추출기(COSMOS660, 경서기계산업)로 환류추출 한 후 100 mesh의 여과망이 부착된 여과조를 이용하여 여과한 후 상등액을 감압 및 농축한 후에 동결 건조하여 본 발명의 조합예 (CB3)을 수득하여 하기 실험의 시료로 사용하였다. Add 20 times the volume of water to the dry weight of herbal ingredients purchased from OmniHub with a certain weight compounding ratio: Baekchul 1.5, Loach 1.5, Gugijagi 1.5, Longan meat 2, Wooslung 1, Tofu 1, Astronomical 1 After refluxing with an extractor (COSMOS660, Kyungseo Machinery Co., Ltd.) at 100 ° C. for 5 hours, the resultant was filtered using a filter tank with a 100 mesh filter net, and the supernatant was decompressed and concentrated and then lyophilized to combine the present invention (CB3). ) Was used as a sample for the following experiment.
실험예 1. 갱년기 동물실험Experimental Example 1. Menopause Animal Experiment
상기 실시예 시료들의 갱년기증후군 개선 효능을 확인하기 위하여, 문헌에 기재된 난소 절제술을 시행한 갱년기 동물 모델에서 하기와 같이 실험을 수행하였다.In order to confirm the effectiveness of improving the menopausal syndrome of the sample samples, the experiment was performed as follows in the menopausal animal model subjected to ovarian resection described in the literature.
1-1. 1-1. 실험 동물Experimental animals
7주령의 ICR 마우스(28~30g)을 ㈜오리엔트바이오(Seoul, Korea)에서 공급받아 동물 실험실에 약 5일간 적응시켜 사용하였으며, 물과 사료는 자유롭게 섭취하도록 하였고, 온도(23 ± 2℃), 습도(50 ± 10%) 및 명암 주기(12 시간)는 자동으로 조절되도록 하였다. Seven-week-old ICR mice (28-30 g) were supplied from Orient Bio Co., Ltd. (Seoul, Korea) and used in animal laboratories for about 5 days. The water and feed were freely consumed, and the temperature (23 ± 2 ℃), Humidity (50 ± 10%) and contrast period (12 hours) were allowed to adjust automatically.
1-2. 실험 방법1-2. Experiment method
1-2-1.1-2-1. 마우스 난소 절제수술Mouse Ovariectomy
Park 등의 방법(Park 등, J Korean Neurosurg Soc. 2010, 48; p309)에 근거하여 8 주령의 ICR 마우스를 마취시키고 등쪽 부분을 가위로 자른 후 왼쪽과 오른쪽의 난소 아래 부분을 봉합사로 잘 묶은 다음 난소 부분을 절제하고 등 부분을 봉합사로 마무리하고 소독한 후 항생제를 투여하고 히팅 패드(heating pad)에서 깨어날 때까지 체온을 유지한 후 갱년기 모델 마우스를 제작하였다. 수술 2주 동안 회복기를 거친 후 실험에 사용하였다.Based on Park et al. (Park et al., J Korean Neurosurg Soc. 2010, 48; p309), anesthetize an 8-week-old ICR mouse, cut the dorsal area with scissors, and then tie the left and right lower ovaries with sutures. The ovary was excised, the back was closed with a suture, disinfected, antibiotics were administered, and body temperature was maintained until waking up from a heating pad. After the recovery period for 2 weeks, it was used for the experiment.
1-2-2. 꼬리 피부 온도 측정1-2-2. Tail skin temperature measurement
난소 절제 수술 2주 후부터 본 발명의 시료들을 한 용량군으로 경구 투여하였다. 대조군(Sham)과 음성대조군(OVX+saline)은 생리 식염수를 경구 투여하였다. 투여 2주 후 마우스의 몸무게를 재고 운동 시작 전 꼬리 피부 온도(Tail Skin Temperature)를 측정하기 위해 마우스를 고정틀(restrainer)에 넣고 5분간 안정화를 시킨 후 꼬리 기저부로부터 1 cm 부분을 1분 간격으로 3회 열화상 카메라(FLIR T600, USA)를 이용하여 꼬리의 온도를 측정(Basal temperature, TB)한 후 트레드밀(Exer-3/6, Columbus instruments, USA)에서 15 m/min 속도로 10분 동안 운동을 한 후 다시 고정틀로 옮겨 1분 간격으로 3회 열화상카메라를 이용하여 꼬리 온도(Forced Exercise Temperature, TE)를 측정하였다(Hideki 등, J Pharmacol Sci, 2005,98:323). 운동 전의 온도는 3회 평균값(TB)을 구하였고, 운동 후 측정한 꼬리 피부 온도는 하기 수학식 1에 따라 Total ΔTST를 계산하였다.Two weeks after ovarian resection, the samples of the present invention were administered orally in one dose group. The control group (Sham) and negative control group (OVX + saline) were orally administered with saline. After 2 weeks of administration, weigh the mouse and measure the tail skin temperature before starting exercise. Place the mouse in the restrainer, stabilize for 5 minutes, and remove 1 cm from the base of the tail every 3 minutes. The tail temperature was measured using a thermal imaging camera (FLIR T600, USA) (Basal temperature, T B ), followed by 10 minutes at 15 m / min on a treadmill (Exer-3 / 6, Columbus instruments, USA). After exercise, the body was moved back to the fixing frame, and the tail temperature (Forced Exercise Temperature, T E ) was measured using a thermal imaging camera three times at 1 minute intervals (Hideki et al., J Pharmacol Sci, 2005, 98: 323). The average temperature before exercise was calculated three times (T B ), and the tail skin temperature measured after exercise was calculated according to Equation 1 below.
[수학식 1][Equation 1]
Total ΔTST = (TE1 - TB) + (TE2 - TB) +(TE3 - TB)Total ΔTST = (T E1 -T B ) + (T E2 -T B ) + (T E3 -T B )
TB : 운동 전의 꼬리 피부 온도 3회 측정값의 평균T B : mean of three measurements of tail skin temperature before exercise
TE1 : 운동 후 1분 후 꼬리 피부 온도 측정값T E1 : Tail skin temperature measurement 1 minute after exercise
TE2 : 운동 후 2분 후 꼬리 피부 온도 측정값T E2 : Tail skin temperature measurement 2 minutes after exercise
TE3 : 운동 후 3분 후 꼬리 피부 온도 측정값T E3 : Tail skin temperature measurement 3 minutes after exercise
갱년기증후군의 증상 중 하나인 열성홍조(hot flush)를 실험하기 위하여 마우스의 난소를 절제하고 2주 동안 실시예 1~3의 추출물을 경구 투여한 후 열화상 카메라를 이용하여 꼬리 피부 온도를 측정하였다. In order to experiment with hot flushes, one of the symptoms of menopausal syndrome, the ovaries of the mice were excised and orally administered with the extracts of Examples 1 to 3 for 2 weeks, and the tail skin temperature was measured using a thermal imaging camera. .
상기 실험 결과, 표 1에서 보는 바와 같이 음성대조군(OVX+saline)에서 TST의 유의성 있는 증가를 확인한 바 난소 절제 수술은 잘 된 것으로 판단할 수 있었다. 실시예 1~3의 추출물을 각각 투여한 실험군은 모두 음성대조군에 비하여, 열성홍조의 지표인 TST가 현저히 감소함을 확인할 수 있었다. As a result of the experiment, as shown in Table 1, a significant increase in the TST in the negative control group (OVX + saline) was confirmed that the ovarian resection was successful. In each of the experimental groups administered the extracts of Examples 1 to 3, it was confirmed that the TST, which is an indicator of febrile flushing, was significantly reduced compared to the negative control group.
추출물의 갱년기 Menopause of extract 열성홍조Hot flush 치료 효과 Therapeutic effect
제 품 \ Mean±SEMProduct \ Mean ± SEM Basal temp.Basal temp. Exercise temp.Exercise temp. ΔTSTΔTST
대조군(Sham)Sham 27.0±0.427.0 ± 0.4 28.5±0.528.5 ± 0.5 4.4±0.74.4 ± 0.7
음성대조군(OVX + saline)Negative Control (OVX + saline) 29.9±0.829.9 ± 0.8 34.8±0.6*34.8 ± 0.6 * 14.7±2.4*14.7 ± 2.4 *
실시예 1 (2g/kg)Example 1 (2 g / kg) 27.3±0.127.3 ± 0.1 29.1±0.529.1 ± 0.5 4.9±1.0# 4.9 ± 1.0 #
실시예 2 (2g/kg)Example 2 (2 g / kg) 27.6±0.227.6 ± 0.2 28.5±0.628.5 ± 0.6 4.8±2.1# 4.8 ± 2.1 #
실시예 3 (2g/kg)Example 3 (2 g / kg) 27.9±0.527.9 ± 0.5 29.2±0.729.2 ± 0.7 4.3±1.9# 4.3 ± 1.9 #
1-2-3. 트레드밀을 이용한 항피로 실험1-2-3. Anti-fatigue experiment using treadmill
갱년기 유발 마우스를 이용하여 실시예 1~3의 추출물 투여에 의한 갱년기 피로 억제 효과를 트레드밀 운동실험으로 평가하였다. Minghua 등의(Mechanisms of Ageing and Development, 2003, 124:771) 방법을 수정하여 트레드밀의 각도를 10도 올린 후 15 m/min 속도로 주행을 시작하고, 3분 간격으로 5 m/min씩 단계적으로 속도를 올려 최대 30 m/min까지 속도를 올리고, 마우스가 주행 불능이 될 때까지의 시간(최대 주행 시간)을 측정하였다.Menopausal-induced mice were evaluated for the effects of menopausal fatigue by the extract administration of Examples 1 to 3 in the treadmill exercise experiment. Modify the method of Minghua et al. (Mechanisms of Ageing and Development, 2003, 124: 771) to raise the angle of the treadmill by 10 degrees, then start driving at 15 m / min, in steps of 5 m / min every three minutes. The speed was raised to a maximum of 30 m / min, and the time until the mouse became inoperable (maximum travel time) was measured.
실시예 1~3의 추출물을 2주간 투여한 후 트레드밀을 이용하여 최대 주행 시간을 측정한 결과, 대조군에서 26.2±1.4분 주행하였고 음성대조군에서는 13.7±1.0분으로 유의성 있는 감소를 보였으며, 본 발명의 시료들은 각각 음성대조군에 비하여 현저하게 증가된 최대 주행 시간을 나타냈다 (표 2). As a result of measuring the maximum running time using the treadmill after administering the extracts of Examples 1 to 3 for 2 weeks, the control group traveled 26.2 ± 1.4 minutes and showed a significant decrease of 13.7 ± 1.0 minutes in the negative control group. Are significantly increased compared to the negative control. The maximum travel time is shown (Table 2).
추출물의 갱년기 항피로 효과Menopausal Antifatigue Effect of Extracts
제 품 \ Mean±SEMProduct \ Mean ± SEM 최대 주행 시간(분)Max driving time (minutes)
대조군(Sham)Sham 26.2±1.426.2 ± 1.4
음성대조군(OVX + saline)Negative Control (OVX + saline) 13.7±1.0*13.7 ± 1.0 *
실시예 1 (2g/kg)Example 1 (2 g / kg) 31.0±3.7# 31.0 ± 3.7 #
실시예 2 (2g/kg)Example 2 (2 g / kg) 27.1±1.9# 27.1 ± 1.9 #
실시예 3 (2g/kg)Example 3 (2 g / kg) 29.9±2.9# 29.9 ± 2.9 #
1-3. 통계처리1-3. Statistical processing
모든 실험 결과는 ANOVA(one way analysis of variance)를 이용하여 통계 처리하였고, 유의성이 인정될 경우 Student-Newman-Keuls Test를 사용하여 p < 0.05 수준 이하에서 유의성 검정을 실시하였다.All experimental results were statistically analyzed using ANOVA (one way analysis of variance), and the significance test was performed at p <0.05 level using Student-Newman-Keuls Test when significance was recognized.
결론적으로 본 발명의 시료들은 갱년기 유발 마우스의 꼬리 피부 온도 실험에서 우수한 열성홍조(hot flush) 감소효과를 나타내고 갱년기 항피로 실험에서도 탁월한 최대 주행 시간을 보인 바, 갱년기 열성홍조(hot flush) 및 갱년기 피로를 개선하거나 치료한다고 판단된다. In conclusion Samples of the present invention exhibited excellent hot flush reduction effect in caudal skin test of climacteric-induced mice and showed excellent maximum running time even in climacteric antifatigue experiments. It is believed to improve or treat menopausal hot flush and menopausal fatigue.
실험예 2. 간이 임상실험Experimental Example 2. Simple Clinical Experiment
폐경을 전후로 갱년기 증후군 증상을 보이는 평균연령 50세의 여성 50명을 대상으로 무작위로 다섯군으로 나누어 상기 실시예의 캅셀 및 시료가 무첨가된 비교군을 1회 2캅셀, 1일 2회씩, 4주간 복용하고, 갱년기 평가 척도인 Kupperman 지수(표 3)의 평균 수치를 구하여, 그 결과를 표 4에 나타내었다.50 females with mean age 50 with menopausal syndrome symptoms before and after menopause were randomly divided into five groups. The average value of the Kupperman index (Table 3), which is a menopausal evaluation scale, was obtained, and the results are shown in Table 4.
Kupperman지수Kupperman Index
증상Symptom 없다none 약간slightly 보통usually 심함Severe
1One 홍조, 열감, 화끈거림Flushing, hot, burning 00 44 88 1212
22 발한(땀)Sweating 00 22 44 66
33 불면증insomnia 00 22 44 66
44 신경질nervousness 00 1One 22 33
55 우울증depression 00 1One 22 33
66 어지러움whirl 00 1One 22 33
77 피로감Fatigue 00 1One 22 33
88 관절통, 근육통Arthralgia, myalgia 00 1One 22 33
99 두통headache 00 1One 22 33
1010 가슴 두근거림Heartbeat 00 1One 22 33
1111 질건조Dryness 00 1One 22 33
표 4로부터, 시료가 무첨가된 대조군에는 뚜렷한 변화가 없는 반면에, 본원 발명의 시료 조합들에서는 뚜렷한 호전을 나타내어 본 발명의 시료들은 갱년기증후군 개선 효과가 뛰어남을 확인할 수 있었다. From Table 4, there was no obvious change in the control without the sample, while the sample combinations of the present invention showed a marked improvement, it was confirmed that the samples of the present invention is excellent in improving the menopausal syndrome.
갱년기증후군에 대한 임상효과 (Kupperman 지수 변화)Clinical Effect on Menopausal Syndrome (Kupperman Index Change)
시료sample 복용 전 점수Score before taking 2주 복용 후 점수Score after taking 2 weeks
갱년기 대조군Climacteric control 28.828.8 24.324.3
갱년기 실시예1Menopause Example 1 29.929.9 10.910.9
갱년기 실시예2Menopause Example 2 28.528.5 9.89.8
갱년기 실시예3Menopause Example 3 30.230.2 10.310.3
하기에 본 발명의 제형화 방법 및 담체의 종류를 설명하나, 본 발명은 이를 한정하고자 함이 아닌 단지 구체적으로 대표적인 제제예를 하기에 설명하고자 함이다.Hereinafter, the formulation method and the type of carrier of the present invention will be described, but the present invention is not intended to be limited thereto, but specifically, a representative formulation example will be described below.
제제예 1. 산제의 제조Formulation Example 1 Preparation of Powder
CB1 ----------------------------------------------- 200 mgCB1 ----------------------------------------------- 200 mg
유당 ---------------------------------------------- 100 mgLactose ---------------------------------------------- 100 mg
탈크 ----------------------------------------------- 10 mgTalc ----------------------------------------------- 10 mg
상기의 성분들을 혼합하고 기밀포에 충진하여 산제를 제조한다.The above ingredients are mixed and filled in an airtight cloth to prepare a powder.
제제예 2. 정제의 제조Formulation Example 2 Preparation of Tablet
CB2 ----------------------------------------------- 200 mgCB2 ----------------------------------------------- 200 mg
옥수수전분 ---------------------------------------- 100 mgCorn Starch ---------------------------------------- 100 mg
유당 ---------------------------------------------- 100 mgLactose ---------------------------------------------- 100 mg
스테아린산 마그네슘 --------------------------------- 2 mgMagnesium Stearate --------------------------------- 2 mg
상기의 성분들을 혼합한 후 통상의 정제의 제조방법에 따라서 타정하여 정제를 제조한다.After mixing the above components, tablets are prepared by tableting according to a conventional method for preparing tablets.
제제예 3. 캅셀제의 제조Formulation Example 3 Preparation of Capsule
CB3 ----------------------------------------------- 200 mgCB3 ----------------------------------------------- 200 mg
결정성 셀룰로오스 ----------------------------------- 3 mgCrystalline Cellulose ----------------------------------- 3 mg
락토오스 ----------------------------------------- 14.8 mgLactose ----------------------------------------- 14.8 mg
마그네슘 스테아레이트 ----------------------------- 0.2 mgMagnesium Stearate ----------------------------- 0.2 mg
통상의 캅셀제 제조방법에 따라 상기의 성분을 혼합하고 젤라틴 캡슐에 충전하여 캅셀제를 제조한다.According to a conventional capsule preparation method, the above ingredients are mixed and filled into gelatin capsules to prepare capsules.
제제예 4. 주사제의 제조Formulation Example 4 Preparation of Injection
CB1 ----------------------------------------------- 200 mgCB1 ----------------------------------------------- 200 mg
만니톨 -------------------------------------------- 180 mgMannitol -------------------------------------------- 180 mg
주사용 멸균 증류수 ------------------------------- 2974 mgSterile Distilled Water for Injection ------------------------------- 2974 mg
Na2HPO4,12H2O ---------------------------------------- 26 mgNa 2 HPO 4, 12H 2 O ---------------------------------------- 26 mg
통상의 주사제의 제조방법에 따라 1 앰플당 (2 ㎖) 상기의 성분 함량으로 제조한다.According to the conventional method for preparing an injection, the amount of the above ingredient is prepared per ampoule (2 ml).
제제예 5. 액제의 제조Formulation Example 5 Preparation of Liquid
CB2 ----------------------------------------------- 200 mgCB2 ----------------------------------------------- 200 mg
이성화당 -------------------------------------------- 10 gIsomerized sugar -------------------------------------------- 10 g
만니톨 ----------------------------------------------- 5 gMannitol ----------------------------------------------- 5 g
정제수 ----------------------------------------------- 적량Purified Water ----------------------------------------------- Proper
통상의 액제의 제조방법에 따라 정제수에 각각의 성분을 가하여 용해시키고 레몬향을 적량 가한 다음 상기의 성분을 혼합한 다음 정제수를 가하여 전체를 정제수를 가하여 전체 100 ml로 조절한 후 갈색병에 충진하여 멸균시켜 액제를 제조한다.After dissolving each component in purified water according to the usual method of preparing a liquid solution, adding a proper amount of lemon aroma, and then mixing the above components, adding purified water and adjusting the whole to 100 ml by adding purified water and filling into a brown bottle. The solution is prepared by sterilization.
제제예 6. 건강 식품(영양보충제)의 제조Formulation Example 6 Preparation of Health Food (Nutrition Supplement)
CB3 --------------------------------------------- 1000 mgCB3 --------------------------------------------- 1000 mg
비타민 혼합물 -------------------------------------- 적량Vitamin Mixture -------------------------------------- Proper
비타민 A 아세테이트 ------------------------------- 70 ㎍Vitamin A Acetate ------------------------------- 70 μg
비타민 E ----------------------------------------- 1.0 ㎎Vitamin E ----------------------------------------- 1.0 mg
비타민 B1 --------------------------------------- 0.13 ㎎Vitamin B1 --------------------------------------- 0.13 mg
비타민 B2 --------------------------------------- 0.15 ㎎Vitamin B2 --------------------------------------- 0.15 mg
비타민 B6 ---------------------------------------- 0.5 ㎎Vitamin B6 ---------------------------------------- 0.5 mg
비타민 B12 --------------------------------------- 0.2 ㎍Vitamin B12 --------------------------------------- 0.2 μg
비타민 C ------------------------------------------ 10 ㎎Vitamin C ------------------------------------------ 10 mg
비오틴 -------------------------------------------- 10 ㎍Biotin -------------------------------------------- 10 μg
니코틴산아미드 ----------------------------------- 1.7 ㎎Nicotinamide ----------------------------------- 1.7 mg
엽산 ---------------------------------------------- 50 ㎍Folic Acid ---------------------------------------------- 50 μg
판토텐산 칼슘 ------------------------------------ 0.5 ㎎Calcium Pantothenate ------------------------------------ 0.5mg
무기질 혼합물 -------------------------------------- 적량Mineral Mixtures -------------------------------------- Suitable
황산제1철 --------------------------------------- 1.75 ㎎Ferrous Sulfate --------------------------------------- 1.75 mg
산화아연 ---------------------------------------- 0.82 ㎎Zinc Oxide ---------------------------------------- 0.82 mg
탄산마그네슘 ------------------------------------ 25.3 ㎎Magnesium Carbonate ------------------------------------ 25.3 mg
제1인산칼륨 --------------------------------------- 15 ㎎Potassium monophosphate -------------------------- 15 mg
제2인산칼슘 --------------------------------------- 55 ㎎Dicalcium Phosphate --------------------------------------- 55 mg
구연산칼륨 ---------------------------------------- 90 ㎎Potassium Citrate ---------------------------------------- 90 mg
탄산칼슘 ----------------------------------------- 100 ㎎Calcium Carbonate ----------------------------------------- 100 mg
염화마그네슘 ------------------------------------ 24.8 ㎎Magnesium Chloride ------------------------------------ 24.8 mg
상기의 비타민 및 미네랄 혼합물의 조성비는 비교적 건강식품에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 그 배합비를 본 발명의 정신 및 범위를 벗어나지 않는다고 간주되는 임의로 변형 실시하여도 무방하다. Although the composition ratio of the said vitamin and mineral mixture was mixed and comprised in the preferable embodiment the component suitable for a healthy food, you may change arbitrarily the compounding ratio considered that it does not deviate from the mind and range of this invention.
제제예 7. 건강 음료의 제조Formulation Example 7 Preparation of Healthy Drink
CB1 -------------------------------------------- 1000 mgCB1 -------------------------------------------- 1000 mg
구연산 ----------------------------------------- 1000 ㎎Citric Acid ----------------------------------------- 1000 mg
올리고당 ----------------------------------------- 100 gOligosaccharide ----------------------------------------- 100 g
타우린 --------------------------------------------- 1 gTaurine --------------------------------------------- 1 g
정제수를 가하여 ---------------------------- 전체 900 ㎖By adding purified water ---------------------------- 900 ml total
통상의 건강음료 제조방법에 따라 상기의 성분을 혼합한 다음, 약 1시간 동안 85℃에서 교반 가열한 후, 만들어진 용액을 여과하여 멸균된 2 ℓ 용기에 취득하여 밀봉 멸균한 뒤 냉장 보관한 다음 본 발명의 건강음료 조성물 제조에 사용한다. After mixing the above components in accordance with the conventional healthy beverage manufacturing method, and stirred and heated at 85 ℃ for about 1 hour, the resulting solution is filtered and obtained in a sterilized 2 L container, sealed sterilization and refrigerated Used to prepare the healthy beverage composition of the invention.
상술한 바와 같이, 다양한 방법으로 본 발명은 변형가능하고, 이러한 변형은 본 발명의 정신 및 범위를 벗어나지 않는 것으로 간주되며, 이러한 모든 변형은 당업자에게는 하기한 본 발명의 청구범위 이내 포함되는 의도임이 자명할 것이다. As described above, the present invention may be modified in various ways, and such modifications are deemed without departing from the spirit and scope of the present invention, and all such modifications are obvious to those skilled in the art to be included within the scope of the following claims. something to do.
상술한 바와 같이, 본 발명의 조합생약 추출물을 대상으로 한 in vivo상 마우스를 이용한 지구적 운동능력 평가실험, 꼬리피부온도를 측정한 바, 실험군이 대조군에 비하여 지구적 운동시간이 증가하고, 꼬리피부온도의 상승이 억제되며, 간이 임상예에서 탁월한 갱년기 증상 개선효과를 나타냄을 확인함으로서, 갱년기증상 치료용 약제 혹은 갱년기 영양보충제 등 건강기능식품 혹은 건강보조식품을 제조하는 원료로 조합 추출물을 활용할 수 있음을 처음으로 확인한 바, 갱년기증후군에 대한 억제, 치료, 예방 및 개선에 유용한 약학조성물, 건강기능식품 및 건강보조식품으로 응용할 수 있다. As described above, the global exercise capacity evaluation experiment using the in vivo mouse targeting the combination herbal extract of the present invention, the tail skin temperature was measured, the experimental group increased the global exercise time compared to the control group, the tail The increase in skin temperature is suppressed, and by confirming that the liver shows excellent menopausal symptoms improvement in clinical cases, the combination extract can be used as a raw material for manufacturing health functional foods or supplements such as drugs for treating menopausal symptoms or menopausal nutritional supplements. It was found for the first time that it can be applied as pharmaceutical composition, health functional food and health supplement food which is useful for suppression, treatment, prevention and improvement of menopausal syndrome.

Claims (16)

  1. 백출, 상심자, 구기자, 용안육, 우슬, 두충 및 천문동으로 구성된 조합생약 추출물을 유효성분으로 함유하는 갱년기증후군의 치료 및 예방용 약학조성물.A pharmaceutical composition for treating and preventing menopausal syndrome, which contains a combination herbal extract consisting of baekchul, sirloin, goji berry, longan meat, hyssop, head worm and astronomical dong as an active ingredient.
  2. 제 1항에 있어서, 상기 조합생약 추출물은 추가적으로, 생강 및 대추로 구성된 하나 이상의 생약 추출물; 비타민 A, 비타민 E, 비타민 B1, 비타민 B2, 비타민 B6, 비타민 B12, 비타민 C, 비오틴, 니코틴산아미드, 엽산, 및 판토텐산, 칼슘으로부터 구성된 군으로부터 선택된 하나 이상의 비타민류; 및/또는 황산 제1철, 산화아연, 탄산마그네슘, 제1인산칼슘, 제2인산칼슘, 구연산칼슘, 젖산칼슘, 탄산칼슘, 및 염화마그네슘으로부터 구성된 군으로부터 선택된 하나 이상의 무기질을 포함함을 특징으로 하는 약학 조성물.According to claim 1, wherein the combination herbal extract further comprises one or more herbal extracts consisting of ginger and jujube; At least one vitamin selected from the group consisting of vitamin A, vitamin E, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, biotin, nicotinamide, folic acid, and pantothenic acid, calcium; And / or at least one mineral selected from the group consisting of ferrous sulfate, zinc oxide, magnesium carbonate, monobasic calcium phosphate, dibasic calcium phosphate, calcium citrate, calcium lactate, calcium carbonate, and magnesium chloride. Pharmaceutical composition.
  3. 제 1항 또는 제 2항에 있어서, The method according to claim 1 or 2,
    상기 조합생약 추출물의 배합 중량부는 (a) 백출, 상심자, 구기자, 용안육, 우슬, 두충 및 천문동의 조합인 경우는, 백출 1 내지 10, 상심자 1 내지 10, 구기자 1 내지 10, 용안육 1 내지 10, 우슬 1 내지 10, 두충 1 내지 10, 및 천문동 1 내지 10의 중량부(w/w)이며; (b) 백출, 상심자, 구기자, 용안육, 우슬, 두충, 천문동, 생강 및 대추의 조합인 경우는, 백출 1 내지 10, 상심자 1 내지 10, 구기자 1 내지 10, 용안육 1 내지 10, 우슬 1 내지 10, 두충 1 내지 10, 천문동 1 내지 10, 생강 1 내지 10 및 대추 1 내지 10의 중량부(w/w)임을 특징으로 하는 약학 조성물.The combined weight of the combination herbal extract is (a) when the combination of Baekchul, Sanggi, Wolfberry, Longan meat, dew, tofu and astronomical dong, Baekchul 1 to 10, beetle 1 to 10, Wolfberry 1 to 10, Yongan meat 1 to 10, wedges 1 to 10, worms 1 to 10, and 1 to 10 parts by weight of astronomical dong (w / w); (b) If the combination of baekchul, sirloin, wolfberry, longan, beef, bean curd, astronomical dong, ginger and jujube, baekchul 1-10, beetle 1-10, wolfberry 1-10, yongan 1-10, dew 1 To 10, Tochung 1 to 10, astronomical dong 1 to 10, ginger 1 to 10 and jujube 1 to 10 parts by weight (w / w) of the pharmaceutical composition.
  4. 제 1항 또는 제 2항에 있어서, The method according to claim 1 or 2,
    상기 조합생약 추출물은 정제수를 포함한 물, C1 내지 C4의 저급알코올 또는 이들의 혼합용매에 가용한 추출물임을 특징으로 하는 약학조성물. The combination herbal extract is a pharmaceutical composition, characterized in that the extract containing water, C1 to C4 lower alcohol or a mixed solvent thereof, including purified water.
  5. 제 1항 또는 제 2항에 있어서, The method according to claim 1 or 2,
    상기 갱년기증후군은 성호르몬의 변화와 연관된, 피로, 열성홍조, 혈관운동증상, 우울, 불안, 어지러움, 두통, 관절통, 근육통, 골다공증, 불면, 질건조증 등등의 증상이나 징후 중 전부 혹은 일부를 특징으로 하는 약학 조성물.The menopausal syndrome is characterized by all or part of the symptoms or signs of fatigue, hot flashes, vasomotor symptoms, depression, anxiety, dizziness, headache, joint pain, myalgia, osteoporosis, insomnia, vaginal dryness and the like associated with changes in sex hormones Pharmaceutical composition.
  6. 백출, 상심자, 구기자, 용안육, 우슬, 두충 및 천문동으로 구성된 조합생약 추출물을 유효성분으로 함유하는 갱년기증후군의 개선 및 예방용 건강기능식품.Health functional food for improving and preventing menopausal syndrome, which contains a combination herbal extract consisting of baekchul, heartache, goji berry, longan meat, hyssop, tofu and astronomical dong as an active ingredient.
  7. 제 6항에 있어서, 상기 조합생약 추출물은 추가적으로, 생강 및 대추로 구성된 하나 이상의 생약 추출물; 비타민 A, 비타민 E, 비타민 B1, 비타민 B2, 비타민 B6, 비타민 B12, 비타민 C, 비오틴, 니코틴산아미드, 엽산, 및 판토텐산 칼슘으로부터 구성된 군으로부터 선택된 하나 이상의 비타민류; 및/또는 황산 제1철, 산화아연, 탄산마그네슘, 제1인산칼슘, 제2인산칼슘, 구연산칼슘, 젖산칼슘, 탄산칼슘,및 염화마그네슘으로부터 구성된 군으로부터 선택된 하나 이상의 무기질을 포함함을 특징으로 하는 건강기능식품.The method of claim 6, wherein the combination herbal extract further comprises one or more herbal extracts consisting of ginger and jujube; At least one vitamin selected from the group consisting of vitamin A, vitamin E, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, biotin, nicotinamide, folic acid, and calcium pantothenate; And / or at least one mineral selected from the group consisting of ferrous sulfate, zinc oxide, magnesium carbonate, monobasic calcium phosphate, dibasic calcium phosphate, calcium citrate, calcium lactate, calcium carbonate, and magnesium chloride. Health functional food.
  8. 제 6항 또는 제 7항에 있어서, The method according to claim 6 or 7,
    상기 조합생약 추출물의 배합 중량부는 (a) 백출, 상심자, 구기자, 용안육, 우슬, 두충 및 천문동의 조합인 경우는, 백출 1 내지 10, 상심자 1 내지 10, 구기자 1 내지 10, 용안육 1 내지 10, 우슬 1 내지 10, 두충 1 내지 10, 및 천문동 1 내지 10의 중량부(w/w)이며; (b) 백출, 상심자, 구기자, 용안육, 우슬, 두충, 천문동, 생강 및 대추의 조합인 경우는, 백출 1 내지 10, 상심자 1 내지 10, 구기자 1 내지 10, 용안육 1 내지 10, 우슬 1 내지 10, 두충 1 내지 10, 천문동 1 내지 10, 생강 1 내지 10 및 대추 1 내지 10의 중량부(w/w)임을 특징으로 하는 건강기능식품.The combined weight of the combination herbal extract is (a) when the combination of Baekchul, Sanggi, Wolfberry, Longan meat, dew, tofu and astronomical dong, Baekchul 1 to 10, beetle 1 to 10, Wolfberry 1 to 10, Yongan meat 1 to 10, wedges 1 to 10, worms 1 to 10, and 1 to 10 parts by weight of astronomical dong (w / w); (b) If the combination of baekchul, sirloin, wolfberry, longan, beef, bean curd, astronomical dong, ginger and jujube, baekchul 1-10, beetle 1-10, wolfberry 1-10, yongan 1-10, dew 1 Health functional foods, characterized in that the weight part (w / w) of 10 to 10, tofu 1 to 10, astronomical dong 1 to 10, ginger 1 to 10 and jujube 1 to 10.
  9. 백출, 상심자, 구기자, 용안육, 우슬, 두충 및 천문동으로 구성된 조합생약 추출물을 유효성분으로 함유하는 피로 증후군 또는 갱년기 증후군의 개선 및 예방용 건강보조식품.A dietary supplement for the improvement and prevention of fatigue syndrome or menopausal syndrome, which contains as an active ingredient a combination herbal extract consisting of baekchul, sirloin, goji berry, longan meat, hyssop, tofu and astronomical dong.
  10. 제 9항에 있어서, 상기 조합생약 추출물은 추가적으로, 생강 및 대추로 구성된 하나 이상의 생약 추출물; 비타민 A, 비타민 E, 비타민 B1, 비타민 B2, 비타민 B6, 비타민 B12, 비타민 C, 비오틴, 니코틴산아미드, 엽산, 및 판토텐산 칼슘으로부터 구성된 군으로부터 선택된 하나 이상의 비타민류; 및/또는 황산 제1철, 산화아연, 탄산마그네슘, 제1인산칼슘, 제2인산칼슘, 구연산칼슘, 젖산칼슘, 탄산칼슘, 및 염화마그네슘으로부터 구성된 군으로부터 선택된 하나 이상의 무기질을 포함함을 특징으로 하는 건강보조식품.10. The method of claim 9, wherein the combination herbal extract further comprises one or more herbal extracts consisting of ginger and jujube; At least one vitamin selected from the group consisting of vitamin A, vitamin E, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, biotin, nicotinamide, folic acid, and calcium pantothenate; And / or at least one mineral selected from the group consisting of ferrous sulfate, zinc oxide, magnesium carbonate, monobasic calcium phosphate, dibasic calcium phosphate, calcium citrate, calcium lactate, calcium carbonate, and magnesium chloride. Health supplement food.
  11. 제 9항 또는 제 10항에 있어서, The method according to claim 9 or 10,
    상기 조합생약 추출물의 배합 중량부는 (a) 백출, 상심자, 구기자, 용안육, 우슬, 두충 및 천문동의 조합인 경우는, 백출 1 내지 10, 상심자 1 내지 10, 구기자 1 내지 10, 용안육 1 내지 10, 우슬 1 내지 10, 두충 1 내지 10, 및 천문동 1 내지 10의 중량부(w/w)이며; (b) 백출, 상심자, 구기자, 용안육, 우슬, 두충, 천문동, 생강 및 대추의 조합인 경우는, 백출 1 내지 10, 상심자 1 내지 10, 구기자 1 내지 10, 용안육 1 내지 10, 우슬 1 내지 10, 두충 1 내지 10, 천문동 1 내지 10, 생강 1 내지 10 및 대추 1 내지 10의 중량부(w/w)임을 특징으로 하는 건강보조식품.The combined weight of the combination herbal extract is (a) when the combination of Baekchul, Sanggi, Wolfberry, Longan meat, dew, tofu and astronomical dong, Baekchul 1 to 10, beetle 1 to 10, Wolfberry 1 to 10, Yongan meat 1 to 10, wedges 1 to 10, worms 1 to 10, and 1 to 10 parts by weight of astronomical dong (w / w); (b) If the combination of baekchul, sirloin, wolfberry, longan, beef, bean curd, astronomical dong, ginger and jujube, baekchul 1-10, beetle 1-10, wolfberry 1-10, yongan 1-10, dew 1 To 10, Tochung 1-10, Cheonmundong 1-10, Ginger 1-10 and Jujube 1 to 10 parts by weight (w / w) of the health supplement.
  12. 백출, 상심자, 구기자, 용안육, 우슬, 두충 및 천문동으로 구성된 조합생약 추출물을 유효성분으로 함유하는 갱년기 영양보충제.A menopausal nutritional supplement containing as an active ingredient a combination herbal extract consisting of baekchul, sirloin, goji berry, longan meat, hyssop, tofu and astronomical dong.
  13. 제 12항에 있어서, 상기 조합생약 추출물은 추가적으로, 생강 및 대추로 구성된 하나 이상의 생약 추출물; 비타민 A, 비타민 E, 비타민 B1, 비타민 B2, 비타민 B6, 비타민 B12, 비타민 C, 비오틴, 니코틴산아미드, 엽산, 및 판토텐산 칼슘으로부터 구성된 군으로부터 선택된 하나 이상의 비타민류; 및/또는 황산 제1철, 산화아연, 탄산마그네슘, 제1인산칼륨, 제2인산칼슘, 구연산 칼륨, 탄산칼슘, 및 염화마그네슘으로부터 구성된 군으로부터 선택된 하나 이상의 무기질을 포함함을 특징으로 하는 갱년기 영양보충제.The method of claim 12, wherein the combination herbal extract further comprises one or more herbal extracts consisting of ginger and jujube; At least one vitamin selected from the group consisting of vitamin A, vitamin E, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, biotin, nicotinamide, folic acid, and calcium pantothenate; And / or at least one mineral selected from the group consisting of ferrous sulfate, zinc oxide, magnesium carbonate, potassium monophosphate, dibasic calcium phosphate, potassium citrate, calcium carbonate, and magnesium chloride. Supplements.
  14. 제 12항 또는 제 13항에 있어서, The method according to claim 12 or 13,
    상기 조합생약 추출물의 배합 중량부는 (a) 백출, 상심자, 구기자, 용안육, 우슬, 두충 및 천문동의 조합인 경우는, 백출 1 내지 10, 상심자 1 내지 10, 구기자 1 내지 10, 용안육 1 내지 10, 우슬 1 내지 10, 두충 1 내지 10, 및 천문동 1 내지 10의 중량부(w/w)이며; (b) 백출, 상심자, 구기자, 용안육, 우슬, 두충, 천문동, 생강 및 대추의 조합인 경우는, 백출 1 내지 10, 상심자 1 내지 10, 구기자 1 내지 10, 용안육 1 내지 10, 우슬 1 내지 10, 두충 1 내지 10, 천문동 1 내지 10, 생강 1 내지 10 및 대추 1 내지 10의 중량부(w/w)임을 특징으로 하는 갱년기 영양보충제.The combined weight of the combination herbal extract is (a) when the combination of Baekchul, Sanggi, Wolfberry, Longan meat, dew, tofu and astronomical dong, Baekchul 1 to 10, beetle 1 to 10, Wolfberry 1 to 10, Yongan meat 1 to 10, wedges 1 to 10, worms 1 to 10, and 1 to 10 parts by weight of astronomical dong (w / w); (b) If the combination of baekchul, sirloin, wolfberry, longan, beef, bean curd, astronomical dong, ginger and jujube, baekchul 1-10, beetle 1-10, wolfberry 1-10, yongan 1-10, dew 1 Menopausal nutritional supplements, characterized in that the weight part (w / w) of 10 to 10, tofu 1 to 10, astronomical dong 1 to 10, ginger 1 to 10 and jujube 1 to 10.
  15. 백출, 상심자, 구기자, 용안육, 우슬, 두충 및 천문동으로 구성된 조합생약 추출물을 갱년기증후군 환자에게 투여함을 포함하는, 갱년기증후군 환자를 치료하기 위한 치료방법.A therapeutic method for treating a climacteric syndrome patient, comprising administering to a climacteric syndrome patient a combination herbal extract consisting of baekchul, heartache, goji berry, longan meat, pulp, head worm and astronomical dong.
  16. 갱년기증후군 치료용 약제를 제조하기 위한 백출, 상심자, 구기자, 용안육, 우슬, 두충 및 천문동으로 구성된 조합생약 추출물의 용도.Use of a combination herbal extract consisting of Baekchul, Bokja, Gugija, Longan meat, dew, head worm and astronomical dong to prepare a medicament for treating menopausal syndrome.
PCT/KR2018/002803 2017-03-23 2018-03-09 Composition for treating and preventing climacteric syndrome containing combined herbal medicinal extract of white atractylis, mori fructus, chinese matrimony vine, longan, achyranthes, eucommia bark, and asparagus cochinchinensis merr. as active ingredient, and use of same WO2018174448A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020170036775A KR101793531B1 (en) 2017-03-23 2017-03-23 A composition and functional food comprising an combination extract of Atractylodes macrocephala KOIDZ, Morus alba L., Lycium chinensis, Euphoria lingan STEUD, Achyranthus japonica NAKAI, Eucommia ulmoides OLIV and Asparagus cochinchinensis MERR for preventing or treating postmenopause syndrome
KR10-2017-0036775 2017-03-23

Publications (1)

Publication Number Publication Date
WO2018174448A1 true WO2018174448A1 (en) 2018-09-27

Family

ID=60383974

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2018/002803 WO2018174448A1 (en) 2017-03-23 2018-03-09 Composition for treating and preventing climacteric syndrome containing combined herbal medicinal extract of white atractylis, mori fructus, chinese matrimony vine, longan, achyranthes, eucommia bark, and asparagus cochinchinensis merr. as active ingredient, and use of same

Country Status (2)

Country Link
KR (1) KR101793531B1 (en)
WO (1) WO2018174448A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115530368A (en) * 2022-07-08 2022-12-30 山东康美药业有限公司 Preparation method of soft extract for tonifying qi and blood, resisting oxidation and delaying aging

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101793531B1 (en) * 2017-03-23 2017-11-03 김순일 A composition and functional food comprising an combination extract of Atractylodes macrocephala KOIDZ, Morus alba L., Lycium chinensis, Euphoria lingan STEUD, Achyranthus japonica NAKAI, Eucommia ulmoides OLIV and Asparagus cochinchinensis MERR for preventing or treating postmenopause syndrome
WO2020085633A1 (en) * 2018-10-24 2020-04-30 에스케이바이오랜드 주식회사 Cosmetic composition comprising hardy rubber tree bark extract for cooling skin or reducing skin redness
CN109846963A (en) * 2019-04-03 2019-06-07 江西安顺堂生物科技有限公司 A kind of health care product tonify the kidney to relieve mental strain, fill blood, alleviating neural anxiety, improving sleep
KR102320679B1 (en) * 2019-06-05 2021-11-02 아주대학교산학협력단 Composition for preventing or treating osteoporosis comprising complex extract of lycii radicis cortex and achyranthes japonica nakai, and analysis method for standardization thereof
CN111700950B (en) * 2020-07-20 2021-12-14 花姐生物科技(杭州)有限公司 Natural-source anti-anxiety sleep-aiding sublingual tablet
KR102425282B1 (en) * 2020-10-14 2022-07-28 주식회사 필홀딩스 Composition including oriental medicine for improvement of muscular pain and process of treating thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000103718A (en) * 1998-09-28 2000-04-11 Pola Chem Ind Inc Composition for improving activity of living body
KR20040010176A (en) * 2002-07-15 2004-01-31 주식회사 한국인삼공사 A functional food Containing herbes composition for female menopausal disorder
KR20130039309A (en) * 2011-10-11 2013-04-19 김선미 Garlic and yolk extract including functionality food composite for health
KR101451755B1 (en) * 2013-08-05 2014-10-16 동우당제약(주) A composition for preventing bone metabolism-related diseases and increasing bone function comprising mix extracts of Mori Fructus and Aralia Continentalis
KR101793531B1 (en) * 2017-03-23 2017-11-03 김순일 A composition and functional food comprising an combination extract of Atractylodes macrocephala KOIDZ, Morus alba L., Lycium chinensis, Euphoria lingan STEUD, Achyranthus japonica NAKAI, Eucommia ulmoides OLIV and Asparagus cochinchinensis MERR for preventing or treating postmenopause syndrome

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000103718A (en) * 1998-09-28 2000-04-11 Pola Chem Ind Inc Composition for improving activity of living body
KR20040010176A (en) * 2002-07-15 2004-01-31 주식회사 한국인삼공사 A functional food Containing herbes composition for female menopausal disorder
KR20130039309A (en) * 2011-10-11 2013-04-19 김선미 Garlic and yolk extract including functionality food composite for health
KR101451755B1 (en) * 2013-08-05 2014-10-16 동우당제약(주) A composition for preventing bone metabolism-related diseases and increasing bone function comprising mix extracts of Mori Fructus and Aralia Continentalis
KR101793531B1 (en) * 2017-03-23 2017-11-03 김순일 A composition and functional food comprising an combination extract of Atractylodes macrocephala KOIDZ, Morus alba L., Lycium chinensis, Euphoria lingan STEUD, Achyranthus japonica NAKAI, Eucommia ulmoides OLIV and Asparagus cochinchinensis MERR for preventing or treating postmenopause syndrome

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GU, HEE-JUN ET AL.: "Two Cases Report of Climacteric Syndrome Were Measured by Kuppertnan's Index", THE JOURNAL OF ORIENTAL OBSTETRICS & GYNECOLOGY, vol. 21, no. 3, 2008, pages 257 - 268, XP053000626 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115530368A (en) * 2022-07-08 2022-12-30 山东康美药业有限公司 Preparation method of soft extract for tonifying qi and blood, resisting oxidation and delaying aging

Also Published As

Publication number Publication date
KR101793531B1 (en) 2017-11-03

Similar Documents

Publication Publication Date Title
WO2018174448A1 (en) Composition for treating and preventing climacteric syndrome containing combined herbal medicinal extract of white atractylis, mori fructus, chinese matrimony vine, longan, achyranthes, eucommia bark, and asparagus cochinchinensis merr. as active ingredient, and use of same
WO2015002391A1 (en) Composition having a function for alleviating premenstrual syndrome and menstrual pain
WO2012050396A2 (en) Pharmaceutical composition including herbal medicine extract for preventing or treating liver cancer
WO2014171781A1 (en) Composition for preventing or treating hangover
WO2016032249A1 (en) Pharmaceutical composition containing vaccinium bracteatum thunb. extract or fraction thereof as active ingredient for preventing or treating neuroinflammation or neuro-degenerative diseases
WO2017116045A1 (en) Composition for preventing and treating climacteric disorder containing extracts of dendropanax morbifera lev. as active ingredient
WO2014200234A1 (en) Composition containing composite extract of rehmannia glutinosa and pueraria lobata for preventing or treating menopausal symptoms
WO2013141581A1 (en) Pharmaceutical composition or health food comprising lonicera coerulea var. edulis fruit extracts as active ingredients for preventing or improving ischemic cerebrovascular diseases
WO2013151192A1 (en) Composition comprising eupatorium spp. extract as active ingredient for preventing and treating obesity and metabolic bone disease
WO2014084616A1 (en) Pharmaceutical composition containing sceptridium japonicum extract for preventing or treating stroke or degenerative brain diseases
WO2016010340A1 (en) Composition for preventing and treating inflammation or allergic diseases, containing gynura procumbens extract as active ingredient, and use thereof
WO2021071269A1 (en) Composition for preventing or treating inflammatory bowel disease comprising extracts of complex herbal medicines
WO2021080297A1 (en) Composition containing evening primrose flower extract as active ingredient for preventing or treating obesity or metabolic syndromes induced thereby
WO2011139118A2 (en) A pharmaceutical composition and a health functional food composition for preventing, treating or improving a gastrointestinal dyskinetic disease
WO2017146486A1 (en) Composition for preventing or treating benign prostatic hyperplasia, containing morus alba linne extract
WO2010008150A2 (en) Composition for the prevention or treatment of osteoporosis, containing a mixture of saururus chinensis and scutellaria baicalensis extracts as an active ingredient
WO2013069934A1 (en) Composition for treating and preventing obesity, containing wheatgrass extract as active ingredient
WO2019209061A1 (en) Bone growth-promoting composition comprising allium fistulosum linn as active ingredient
WO2015194809A1 (en) Composition for immunoregulating and immune-enhancing comprising dendropanax morbifera léveille extract as effective ingredient and use thereof
WO2018174424A1 (en) Pharmaceutical composition for prevention or treatment of gynecological diseases containing extract of sarcodon imbricatus as active ingredient
WO2012105816A2 (en) Composition for preventing and treating diabetes and diabetes complications comprising amphicarpaea edgeworthii var. trisperma powder or an extract thereof
KR102410771B1 (en) Composition for preventing or treating sarcopenia comprising blueberry extract
WO2011078479A2 (en) A composition comprising the extract of prunella vulgaris l. for preventing and treating adhd disease and the use thereof
WO2017082501A1 (en) Composition for preventing or treating menopausal disorders, containing tetragonia tetragonoides (pall.) kuntze extract
WO2015105373A1 (en) Composition for prevention or treatment of asthma, comprising e uonymus alatus extract or fraction thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18770997

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18770997

Country of ref document: EP

Kind code of ref document: A1